| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | SH3 domain binding | DOCK4 WIPF1 ADAM9 CNTNAP1 WIPF3 PRRT2 DNAJC6 SHANK3 PTPN12 MYPN ERRFI1 SOS1 | 1.91e-10 | 143 | 132 | 12 | GO:0017124 |
| GeneOntologyMolecularFunction | protein domain specific binding | DOCK4 SORBS2 WIPF1 ADAM9 CNTNAP1 WIPF3 DAB1 NFASC TACC2 PRRT2 DNAJC6 SHANK3 GAB2 GRIP1 DLGAP3 PPARGC1B PTPN12 TJP1 MYPN SCN5A ERRFI1 IRS2 SOS1 | 1.38e-08 | 875 | 132 | 23 | GO:0019904 |
| GeneOntologyMolecularFunction | actin binding | BIN1 SHROOM3 WIPF1 COBLL1 SPTBN2 MTSS1 WIPF3 SHANK3 MPRIP SMTN XIRP2 MYPN SSH2 WASF1 | 3.58e-06 | 479 | 132 | 14 | GO:0003779 |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | BIN1 SHROOM3 WIPF1 COBLL1 SPTBN2 MTSS1 WIPF3 BRSK2 ARFGEF1 SHANK3 ENKD1 MPRIP SMTN AP1G1 XIRP2 MYPN SCN5A MTCL1 SSH2 WASF1 | 3.56e-05 | 1099 | 132 | 20 | GO:0008092 |
| GeneOntologyMolecularFunction | GTPase activator activity | DOCK4 ARHGAP32 ARFGEF1 TBC1D10B TBC1D22A ERRFI1 DEPDC5 AGAP2 SOS1 | 1.01e-04 | 279 | 132 | 9 | GO:0005096 |
| GeneOntologyMolecularFunction | protein kinase binding | DOCK4 SASH1 CDK12 ADAM9 BRSK2 PTPN23 NR4A3 TESK1 GAB2 PTK2B NBEAL2 SCN5A ERRFI1 IRS2 MAP2K3 AGAP2 | 2.13e-04 | 873 | 132 | 16 | GO:0019901 |
| GeneOntologyMolecularFunction | molecular adaptor activity | TRERF1 BIN1 SORBS2 SASH1 RETREG2 PPRC1 NACA CHD4 ZC3H18 SHANK3 GAB2 GRIP1 KMT2C DLGAP3 PPARGC1B AP1G1 BAZ2A YAP1 IRS2 TAF6 SOS1 | 2.20e-04 | 1356 | 132 | 21 | GO:0060090 |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | TRERF1 BIN1 SORBS2 RETREG2 PPRC1 NACA CHD4 ZC3H18 SHANK3 GAB2 GRIP1 KMT2C PPARGC1B AP1G1 BAZ2A YAP1 IRS2 TAF6 SOS1 | 2.25e-04 | 1160 | 132 | 19 | GO:0030674 |
| GeneOntologyMolecularFunction | signaling receptor complex adaptor activity | 4.47e-04 | 54 | 132 | 4 | GO:0030159 | |
| GeneOntologyMolecularFunction | kinase binding | DOCK4 SASH1 CDK12 ADAM9 BRSK2 PTPN23 NR4A3 TESK1 GAB2 PTK2B NBEAL2 SCN5A ERRFI1 IRS2 MAP2K3 AGAP2 | 6.69e-04 | 969 | 132 | 16 | GO:0019900 |
| GeneOntologyMolecularFunction | histone H3K4 monomethyltransferase activity | 1.18e-03 | 8 | 132 | 2 | GO:0140945 | |
| GeneOntologyMolecularFunction | transcription factor binding | TRERF1 PPRC1 PCLO NACA NR4A2 NR4A3 TACC2 CHD4 TFCP2 PPARGC1B BAZ2A YAP1 TAF6 | 1.47e-03 | 753 | 132 | 13 | GO:0008134 |
| GeneOntologyMolecularFunction | phosphatidylinositol 3-kinase activator activity | 1.51e-03 | 9 | 132 | 2 | GO:0141038 | |
| GeneOntologyMolecularFunction | nuclear receptor binding | 1.54e-03 | 187 | 132 | 6 | GO:0016922 | |
| GeneOntologyMolecularFunction | signaling adaptor activity | 1.67e-03 | 129 | 132 | 5 | GO:0035591 | |
| GeneOntologyMolecularFunction | histone H3K4 trimethyltransferase activity | 1.89e-03 | 10 | 132 | 2 | GO:0140999 | |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | DOCK4 ARHGAP32 ARFGEF1 PLEKHG4B TBC1D10B TBC1D22A ERRFI1 DEPDC5 AGAP2 SOS1 | 2.01e-03 | 507 | 132 | 10 | GO:0060589 |
| GeneOntologyMolecularFunction | GTPase regulator activity | DOCK4 ARHGAP32 ARFGEF1 PLEKHG4B TBC1D10B TBC1D22A ERRFI1 DEPDC5 AGAP2 SOS1 | 2.01e-03 | 507 | 132 | 10 | GO:0030695 |
| GeneOntologyMolecularFunction | collagen binding | 2.05e-03 | 81 | 132 | 4 | GO:0005518 | |
| GeneOntologyMolecularFunction | glutamate receptor binding | 2.05e-03 | 81 | 132 | 4 | GO:0035254 | |
| GeneOntologyBiologicalProcess | actin cytoskeleton organization | BIN1 SHROOM3 WIPF1 PCLO SPTBN2 MTSS1 WIPF3 BRSK2 ARFGEF1 TESK1 SHANK3 SMTN PTK2B PPARGC1B NPHS2 XIRP2 TJP1 MYPN SSH2 WASF1 TNXB AGAP2 | 6.89e-09 | 803 | 131 | 22 | GO:0030036 |
| GeneOntologyBiologicalProcess | actin filament-based process | BIN1 SHROOM3 WIPF1 PCLO SPTBN2 MTSS1 WIPF3 BRSK2 ARFGEF1 TESK1 SHANK3 SMTN PTK2B PPARGC1B NPHS2 XIRP2 TJP1 MYPN SCN5A SSH2 WASF1 TNXB AGAP2 | 1.41e-08 | 912 | 131 | 23 | GO:0030029 |
| GeneOntologyBiologicalProcess | supramolecular fiber organization | BIN1 SHROOM3 COL12A1 WIPF1 SPTBN2 MTSS1 WIPF3 ARFGEF1 COL5A3 TACC2 NCKAP5L TESK1 SHANK3 PTK2B PPARGC1B XIRP2 TJP1 MYPN SSH2 WASF1 TNXB | 6.50e-07 | 957 | 131 | 21 | GO:0097435 |
| GeneOntologyBiologicalProcess | actin filament organization | BIN1 SHROOM3 WIPF1 SPTBN2 MTSS1 WIPF3 ARFGEF1 TESK1 SHANK3 PTK2B PPARGC1B XIRP2 TJP1 SSH2 WASF1 | 8.63e-07 | 509 | 131 | 15 | GO:0007015 |
| GeneOntologyBiologicalProcess | regulation of actin filament organization | BIN1 SPTBN2 MTSS1 ARFGEF1 TESK1 SHANK3 PTK2B XIRP2 TJP1 SSH2 WASF1 | 3.47e-06 | 300 | 131 | 11 | GO:0110053 |
| GeneOntologyBiologicalProcess | cell-cell junction maintenance | 1.25e-05 | 23 | 131 | 4 | GO:0045217 | |
| GeneOntologyBiologicalProcess | adherens junction maintenance | 2.05e-05 | 9 | 131 | 3 | GO:0034334 | |
| GeneOntologyBiologicalProcess | regulation of actin filament-based process | BIN1 SPTBN2 MTSS1 ARFGEF1 TESK1 SHANK3 PTK2B XIRP2 TJP1 SCN5A SSH2 WASF1 | 2.35e-05 | 438 | 131 | 12 | GO:0032970 |
| GeneOntologyBiologicalProcess | regulation of supramolecular fiber organization | BIN1 SPTBN2 MTSS1 ARFGEF1 TESK1 SHANK3 PTK2B XIRP2 TJP1 SSH2 WASF1 TNXB | 2.35e-05 | 438 | 131 | 12 | GO:1902903 |
| GeneOntologyBiologicalProcess | regulation of actin cytoskeleton organization | BIN1 SPTBN2 MTSS1 ARFGEF1 TESK1 SHANK3 PTK2B XIRP2 TJP1 SSH2 WASF1 | 3.48e-05 | 384 | 131 | 11 | GO:0032956 |
| GeneOntologyBiologicalProcess | cell junction organization | SORBS2 PCLO SPTBN2 CNTNAP1 MTSS1 DAB1 PTPN23 NFASC CHD4 SHANK3 PTK2B SLC8A2 DLGAP3 XIRP2 TJP1 PEAK1 PLEKHA7 WASF1 | 4.47e-05 | 974 | 131 | 18 | GO:0034330 |
| GeneOntologyBiologicalProcess | cell junction maintenance | 5.83e-05 | 65 | 131 | 5 | GO:0034331 | |
| GeneOntologyBiologicalProcess | actin polymerization or depolymerization | 8.83e-05 | 222 | 131 | 8 | GO:0008154 | |
| GeneOntologyBiologicalProcess | cell morphogenesis | ARHGAP32 SHROOM3 CNTNAP1 BRSK2 DAB1 NR4A2 NFASC NR4A3 PDZD7 PRAG1 SHANK3 GRIP1 PLEKHG4B PTK2B YAP1 NBEAL2 MYPN WASF1 SOS1 | 1.95e-04 | 1194 | 131 | 19 | GO:0000902 |
| GeneOntologyBiologicalProcess | vesicle-mediated transport in synapse | 2.15e-04 | 321 | 131 | 9 | GO:0099003 | |
| GeneOntologyBiologicalProcess | actin filament polymerization | 2.15e-04 | 190 | 131 | 7 | GO:0030041 | |
| GeneOntologyBiologicalProcess | synaptic vesicle cycle | 2.89e-04 | 264 | 131 | 8 | GO:0099504 | |
| GeneOntologyBiologicalProcess | regulation of type B pancreatic cell proliferation | 3.06e-04 | 21 | 131 | 3 | GO:0061469 | |
| GeneOntologyCellularComponent | anchoring junction | SHROOM3 SORBS2 ADAM9 SPTBN2 CNTNAP1 MTSS1 NFASC PRAG1 MPRIP PLEKHG4B PTK2B NPHS2 PTPN12 XIRP2 TJP1 YAP1 SCN5A SSH2 PEAK1 PLEKHA7 WASF1 | 8.20e-07 | 976 | 132 | 21 | GO:0070161 |
| GeneOntologyCellularComponent | actin cytoskeleton | ARHGAP32 BIN1 SHROOM3 SORBS2 WIPF1 SPTBN2 MTSS1 SPPL2B MPRIP SMTN PTPN12 XIRP2 TJP1 PEAK1 WASF1 | 3.70e-06 | 576 | 132 | 15 | GO:0015629 |
| GeneOntologyCellularComponent | paranodal junction | 3.91e-05 | 11 | 132 | 3 | GO:0033010 | |
| GeneOntologyCellularComponent | septate junction | 3.96e-05 | 2 | 132 | 2 | GO:0005918 | |
| GeneOntologyCellularComponent | focal adhesion | SORBS2 ADAM9 NFASC PRAG1 MPRIP PTK2B PTPN12 XIRP2 SSH2 PEAK1 WASF1 | 9.33e-05 | 431 | 132 | 11 | GO:0005925 |
| GeneOntologyCellularComponent | cell-substrate junction | SORBS2 ADAM9 NFASC PRAG1 MPRIP PTK2B PTPN12 XIRP2 SSH2 PEAK1 WASF1 | 1.19e-04 | 443 | 132 | 11 | GO:0030055 |
| GeneOntologyCellularComponent | asymmetric synapse | ARHGAP32 PCLO CHD4 PRRT2 DNAJC6 SHANK3 GRIP1 PTK2B SLC8A2 DLGAP3 SYN2 | 2.26e-04 | 477 | 132 | 11 | GO:0032279 |
| GeneOntologyCellularComponent | Z disc | 3.99e-04 | 151 | 132 | 6 | GO:0030018 | |
| GeneOntologyCellularComponent | nuclear speck | 4.17e-04 | 431 | 132 | 10 | GO:0016607 | |
| GeneOntologyCellularComponent | neuron to neuron synapse | ARHGAP32 PCLO CHD4 PRRT2 DNAJC6 SHANK3 GRIP1 PTK2B SLC8A2 DLGAP3 SYN2 | 4.92e-04 | 523 | 132 | 11 | GO:0098984 |
| GeneOntologyCellularComponent | postsynaptic density | ARHGAP32 PCLO PRRT2 DNAJC6 SHANK3 GRIP1 PTK2B SLC8A2 DLGAP3 SYN2 | 5.93e-04 | 451 | 132 | 10 | GO:0014069 |
| GeneOntologyCellularComponent | I band | 6.58e-04 | 166 | 132 | 6 | GO:0031674 | |
| GeneOntologyCellularComponent | glutamatergic synapse | VGF BIN1 PCLO SPTBN2 CNTNAP1 DAB1 CHD4 PRRT2 SHANK3 GRIP1 PTK2B DLGAP3 SYN2 AGAP2 | 6.66e-04 | 817 | 132 | 14 | GO:0098978 |
| GeneOntologyCellularComponent | dendritic spine | 8.84e-04 | 242 | 132 | 7 | GO:0043197 | |
| GeneOntologyCellularComponent | neuron spine | 9.95e-04 | 247 | 132 | 7 | GO:0044309 | |
| GeneOntologyCellularComponent | supramolecular fiber | COL6A3 BIN1 SHROOM3 SORBS2 WIPF1 COL5A3 NCKAP5L ENKD1 RYR1 SMTN GRIP1 SLC8A2 XIRP2 MYPN SCN5A MTCL1 CEP170B | 1.22e-03 | 1179 | 132 | 17 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | COL6A3 BIN1 SHROOM3 SORBS2 WIPF1 COL5A3 NCKAP5L ENKD1 RYR1 SMTN GRIP1 SLC8A2 XIRP2 MYPN SCN5A MTCL1 CEP170B | 1.31e-03 | 1187 | 132 | 17 | GO:0099081 |
| GeneOntologyCellularComponent | cell-cell junction | SHROOM3 SPTBN2 CNTNAP1 MTSS1 NFASC PLEKHG4B NPHS2 TJP1 YAP1 SCN5A PLEKHA7 | 1.33e-03 | 591 | 132 | 11 | GO:0005911 |
| GeneOntologyCellularComponent | postsynaptic specialization | ARHGAP32 PCLO PRRT2 DNAJC6 SHANK3 GRIP1 PTK2B SLC8A2 DLGAP3 SYN2 | 1.36e-03 | 503 | 132 | 10 | GO:0099572 |
| GeneOntologyCellularComponent | somatodendritic compartment | VGF ZC3H14 ARHGAP32 BIN1 SORBS2 PCLO SPTBN2 DAB1 NFASC PRRT2 SHANK3 GRIP1 PTK2B SLC8A2 DLGAP3 AGAP2 SOS1 | 1.89e-03 | 1228 | 132 | 17 | GO:0036477 |
| GeneOntologyCellularComponent | axon terminus | 2.20e-03 | 210 | 132 | 6 | GO:0043679 | |
| GeneOntologyCellularComponent | perinuclear region of cytoplasm | SORBS2 PCLO SPTBN2 BRSK2 DAB1 AGGF1 ARFGEF1 TESK1 RYR1 GRIP1 PTK2B AP1G1 SCN5A DEPDC5 | 2.35e-03 | 934 | 132 | 14 | GO:0048471 |
| GeneOntologyCellularComponent | nuclear protein-containing complex | TRERF1 BIN1 DEAF1 INTS12 KMT2B CDK12 BICRA SF3A1 ARFGEF1 CHD4 BAHD1 WAC KMT2C PPARGC1B BAZ2A YAP1 AFF1 TAF6 | 2.59e-03 | 1377 | 132 | 18 | GO:0140513 |
| GeneOntologyCellularComponent | dendrite | ZC3H14 ARHGAP32 BIN1 SORBS2 PCLO NFASC PRRT2 SHANK3 GRIP1 PTK2B SLC8A2 DLGAP3 AGAP2 | 3.07e-03 | 858 | 132 | 13 | GO:0030425 |
| GeneOntologyCellularComponent | dendritic tree | ZC3H14 ARHGAP32 BIN1 SORBS2 PCLO NFASC PRRT2 SHANK3 GRIP1 PTK2B SLC8A2 DLGAP3 AGAP2 | 3.14e-03 | 860 | 132 | 13 | GO:0097447 |
| GeneOntologyCellularComponent | apical junction complex | 3.32e-03 | 158 | 132 | 5 | GO:0043296 | |
| GeneOntologyCellularComponent | chromatin silencing complex | 3.43e-03 | 14 | 132 | 2 | GO:0005677 | |
| Domain | WH2 | 6.71e-08 | 16 | 132 | 5 | PF02205 | |
| Domain | WH2_dom | 3.04e-07 | 21 | 132 | 5 | IPR003124 | |
| Domain | WH2 | 6.24e-07 | 24 | 132 | 5 | PS51082 | |
| Domain | WH2 | 2.26e-06 | 14 | 132 | 4 | SM00246 | |
| Domain | SH3_2 | 2.54e-06 | 86 | 132 | 7 | PF07653 | |
| Domain | SH3_2 | 2.54e-06 | 86 | 132 | 7 | IPR011511 | |
| Domain | PHD | 1.50e-05 | 75 | 132 | 6 | PF00628 | |
| Domain | Znf_PHD-finger | 2.03e-05 | 79 | 132 | 6 | IPR019787 | |
| Domain | PHD | 4.00e-05 | 89 | 132 | 6 | SM00249 | |
| Domain | Znf_PHD | 4.53e-05 | 91 | 132 | 6 | IPR001965 | |
| Domain | ZF_PHD_2 | 5.77e-05 | 95 | 132 | 6 | PS50016 | |
| Domain | ZF_PHD_1 | 6.12e-05 | 96 | 132 | 6 | PS01359 | |
| Domain | Znf_FYVE_PHD | 8.41e-05 | 147 | 132 | 7 | IPR011011 | |
| Domain | Nuc_orph_rcpt | 1.48e-04 | 3 | 132 | 2 | IPR003070 | |
| Domain | SH3 | 1.52e-04 | 216 | 132 | 8 | SM00326 | |
| Domain | SH3 | 1.52e-04 | 216 | 132 | 8 | PS50002 | |
| Domain | SH3_domain | 1.72e-04 | 220 | 132 | 8 | IPR001452 | |
| Domain | PH_dom-like | SPTBN2 DAB1 GAB2 MPRIP PLEKHG4B PTK2B NBEAL2 IRS2 PLEKHA7 AGAP2 SOS1 | 2.23e-04 | 426 | 132 | 11 | IPR011993 |
| Domain | CAT-like_dom | 2.95e-04 | 4 | 132 | 2 | IPR023213 | |
| Domain | FAM47 | 2.95e-04 | 4 | 132 | 2 | PF14642 | |
| Domain | 2-oxoacid_dh | 2.95e-04 | 4 | 132 | 2 | PF00198 | |
| Domain | 2-oxoacid_DH_actylTfrase | 2.95e-04 | 4 | 132 | 2 | IPR001078 | |
| Domain | DDT | 2.95e-04 | 4 | 132 | 2 | PF02791 | |
| Domain | - | 2.95e-04 | 4 | 132 | 2 | 3.30.559.10 | |
| Domain | FAM47 | 2.95e-04 | 4 | 132 | 2 | IPR032743 | |
| Domain | FYrich_C | 4.89e-04 | 5 | 132 | 2 | IPR003889 | |
| Domain | FYrich_N | 4.89e-04 | 5 | 132 | 2 | IPR003888 | |
| Domain | DDT | 4.89e-04 | 5 | 132 | 2 | SM00571 | |
| Domain | FYRC | 4.89e-04 | 5 | 132 | 2 | SM00542 | |
| Domain | FYRN | 4.89e-04 | 5 | 132 | 2 | SM00541 | |
| Domain | 2-oxoA_DH_lipoyl-BS | 4.89e-04 | 5 | 132 | 2 | IPR003016 | |
| Domain | DDT_dom | 4.89e-04 | 5 | 132 | 2 | IPR018501 | |
| Domain | WHIM2_dom | 4.89e-04 | 5 | 132 | 2 | IPR028941 | |
| Domain | WSD | 4.89e-04 | 5 | 132 | 2 | PF15613 | |
| Domain | FYRN | 4.89e-04 | 5 | 132 | 2 | PF05964 | |
| Domain | FYRC | 4.89e-04 | 5 | 132 | 2 | PF05965 | |
| Domain | FYRC | 4.89e-04 | 5 | 132 | 2 | PS51543 | |
| Domain | FYRN | 4.89e-04 | 5 | 132 | 2 | PS51542 | |
| Domain | LIPOYL | 4.89e-04 | 5 | 132 | 2 | PS00189 | |
| Domain | PDZ | 7.17e-04 | 151 | 132 | 6 | PS50106 | |
| Domain | DDT | 7.30e-04 | 6 | 132 | 2 | PS50827 | |
| Domain | PDZ | 7.42e-04 | 152 | 132 | 6 | IPR001478 | |
| Domain | Bromodomain_CS | 7.97e-04 | 26 | 132 | 3 | IPR018359 | |
| Domain | PH | 8.17e-04 | 278 | 132 | 8 | SM00233 | |
| Domain | PH_DOMAIN | 8.37e-04 | 279 | 132 | 8 | PS50003 | |
| Domain | PH_domain | 8.56e-04 | 280 | 132 | 8 | IPR001849 | |
| Domain | AT_hook | 8.91e-04 | 27 | 132 | 3 | SM00384 | |
| Domain | AT_hook_DNA-bd_motif | 8.91e-04 | 27 | 132 | 3 | IPR017956 | |
| Domain | PH | 1.23e-03 | 229 | 132 | 7 | PF00169 | |
| Domain | - | 1.35e-03 | 8 | 132 | 2 | 3.30.890.10 | |
| Domain | Biotin_lipoyl | 1.73e-03 | 9 | 132 | 2 | PF00364 | |
| Domain | - | 1.86e-03 | 391 | 132 | 9 | 2.30.29.30 | |
| Domain | BIOTINYL_LIPOYL | 2.15e-03 | 10 | 132 | 2 | PS50968 | |
| Domain | Biotin_lipoyl | 2.15e-03 | 10 | 132 | 2 | IPR000089 | |
| Domain | BROMODOMAIN_1 | 2.25e-03 | 37 | 132 | 3 | PS00633 | |
| Domain | SH3_9 | 2.27e-03 | 78 | 132 | 4 | PF14604 | |
| Domain | Bromodomain | 2.43e-03 | 38 | 132 | 3 | PF00439 | |
| Domain | MBD | 2.62e-03 | 11 | 132 | 2 | SM00391 | |
| Domain | MBD | 2.62e-03 | 11 | 132 | 2 | PS50982 | |
| Domain | Methyl_CpG_DNA-bd | 2.62e-03 | 11 | 132 | 2 | IPR001739 | |
| Domain | MBD | 2.62e-03 | 11 | 132 | 2 | PF01429 | |
| Domain | DNA-bd_dom | 2.62e-03 | 11 | 132 | 2 | IPR016177 | |
| Domain | BROMODOMAIN_2 | 3.02e-03 | 41 | 132 | 3 | PS50014 | |
| Domain | Single_hybrid_motif | 3.12e-03 | 12 | 132 | 2 | IPR011053 | |
| Domain | TYR_PHOSPHATASE_1 | 3.24e-03 | 86 | 132 | 4 | PS00383 | |
| Domain | Bromodomain | 3.24e-03 | 42 | 132 | 3 | IPR001487 | |
| Domain | BROMO | 3.24e-03 | 42 | 132 | 3 | SM00297 | |
| Domain | - | 3.24e-03 | 42 | 132 | 3 | 1.20.920.10 | |
| Domain | PDZ | 3.28e-03 | 141 | 132 | 5 | PF00595 | |
| Domain | TYR_PHOSPHATASE_dom | 3.37e-03 | 87 | 132 | 4 | IPR000387 | |
| Domain | TYR_PHOSPHATASE_2 | 3.37e-03 | 87 | 132 | 4 | PS50056 | |
| Domain | MIRO-like | 3.67e-03 | 13 | 132 | 2 | IPR013684 | |
| Domain | Roc | 3.67e-03 | 13 | 132 | 2 | PF08477 | |
| Domain | - | 3.67e-03 | 13 | 132 | 2 | 2.10.10.10 | |
| Domain | PDZ | 4.04e-03 | 148 | 132 | 5 | SM00228 | |
| Domain | - | 4.12e-03 | 92 | 132 | 4 | 3.90.190.10 | |
| Domain | FN_type2_col-bd | 4.27e-03 | 14 | 132 | 2 | IPR000562 | |
| Domain | FN2_2 | 4.27e-03 | 14 | 132 | 2 | PS51092 | |
| Domain | FN2_1 | 4.27e-03 | 14 | 132 | 2 | PS00023 | |
| Domain | fn2 | 4.27e-03 | 14 | 132 | 2 | PF00040 | |
| Domain | FN2 | 4.27e-03 | 14 | 132 | 2 | SM00059 | |
| Domain | - | 4.27e-03 | 150 | 132 | 5 | 2.30.42.10 | |
| Domain | WW | 4.46e-03 | 47 | 132 | 3 | PF00397 | |
| Domain | - | 4.65e-03 | 449 | 132 | 9 | 3.30.40.10 | |
| Domain | WW | 4.73e-03 | 48 | 132 | 3 | SM00456 | |
| Domain | PROTEIN_KINASE_TYR | 4.98e-03 | 97 | 132 | 4 | PS00109 | |
| Domain | Tyr_kinase_AS | 4.98e-03 | 97 | 132 | 4 | IPR008266 | |
| Domain | Prot-tyrosine_phosphatase-like | 5.35e-03 | 99 | 132 | 4 | IPR029021 | |
| Domain | Znf_RING/FYVE/PHD | 5.36e-03 | 459 | 132 | 9 | IPR013083 | |
| Domain | Post-SET_dom | 5.58e-03 | 16 | 132 | 2 | IPR003616 | |
| Domain | PostSET | 5.58e-03 | 16 | 132 | 2 | SM00508 | |
| Domain | AT_hook | 5.58e-03 | 16 | 132 | 2 | PF02178 | |
| Domain | POST_SET | 5.58e-03 | 16 | 132 | 2 | PS50868 | |
| Domain | WW_DOMAIN_1 | 5.61e-03 | 51 | 132 | 3 | PS01159 | |
| Domain | WW_DOMAIN_2 | 5.61e-03 | 51 | 132 | 3 | PS50020 | |
| Domain | WW_dom | 5.92e-03 | 52 | 132 | 3 | IPR001202 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | DOCK4 ARHGAP32 SHROOM3 SORBS2 AMER1 INTS12 SASH1 COBLL1 BRSK2 NCKAP5L PRAG1 TESK1 CIC ENKD1 GAB2 MPRIP GRIP1 NHSL1 PTK2B TBC1D10B MAP7D1 TJP1 YAP1 NAV2 IRS2 MTCL1 SSH2 PEAK1 PLEKHA7 CEP170B | 2.51e-20 | 861 | 134 | 30 | 36931259 |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | SHROOM3 KMT2B ZNF628 PPRC1 CDK12 BICRA SPEG POMGNT1 SPPL2B PRAG1 TESK1 BAHD1 CIC RYR1 MPRIP RABL6 HIVEP3 NHSL1 KMT2C BRD2 NBEAL2 SCN5A NAV2 DEPDC5 IRS2 SYVN1 CEP170B GAREM1 | 1.86e-15 | 1105 | 134 | 28 | 35748872 |
| Pubmed | ARHGAP32 BIN1 SORBS2 PRR36 PCLO SPTBN2 CNTNAP1 BRSK2 NFASC DNAJC6 SHANK3 PDHX MPRIP NHSL1 PTK2B SLC8A2 DLGAP3 MAP7D1 AP1G1 TJP1 CRACDL SYN2 DLST SSH2 PEAK1 PLEKHA7 WASF1 PRRC2A CEP170B AGAP2 | 2.34e-14 | 1431 | 134 | 30 | 37142655 | |
| Pubmed | TRERF1 VGF ARHGAP32 BIN1 SHROOM3 SORBS2 PRR36 ADAM9 SPTBN2 CNTNAP1 NFASC CHD4 DNAJC6 SHANK3 MPRIP DLGAP3 MAP7D1 TJP1 YLPM1 MTCL1 SSH2 WASF1 PRRC2A CEP170B AGAP2 | 4.27e-14 | 963 | 134 | 25 | 28671696 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | TRERF1 BIN1 SORBS2 DEAF1 KMT2B CDK12 SF3A1 CHD4 ZC3H18 CIC SMTN TBC1D10B BRD2 PAPOLA BAZ2A YAP1 YLPM1 AFF1 IRS2 TAF6 PRRC2A SOS1 | 2.83e-13 | 774 | 134 | 22 | 15302935 |
| Pubmed | 8.93e-12 | 103 | 134 | 10 | 21706016 | ||
| Pubmed | Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling. | ARHGAP32 SORBS2 ADAM9 PCLO SPTBN2 CNTNAP1 PRAG1 SHANK3 PTK2B DLGAP3 WASF1 CEP170B AGAP2 | 7.84e-11 | 281 | 134 | 13 | 28706196 |
| Pubmed | ARHGAP32 SORBS2 ADAM9 SPTBN2 CNTNAP1 NFASC DNAJC6 SHANK3 MPRIP DLGAP3 WASF1 AGAP2 | 2.97e-10 | 251 | 134 | 12 | 27507650 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | ZC3H14 CDK12 SF3A1 NACA PTPN23 TACC2 CHD4 CIC TFCP2 WAC MPRIP PTPN12 PAPOLA BAZ2A TJP1 YLPM1 JPT1 IRS2 TAF6 PRRC2A | 5.61e-10 | 934 | 134 | 20 | 33916271 |
| Pubmed | ARHGAP32 WIPF1 BICRA COBLL1 SPTBN2 PTPN23 NCKAP5L CIC ENKD1 GAB2 KMT2C ERRFI1 NAV2 GAREM1 SOS1 | 7.30e-10 | 486 | 134 | 15 | 20936779 | |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | TRERF1 ARHGAP32 SHROOM3 BICRA CIC PLEKHG4B ZNF469 XIRP2 YAP1 YLPM1 AFF1 PLEKHA7 GAREM1 SOS1 | 1.40e-09 | 430 | 134 | 14 | 35044719 |
| Pubmed | DOCK4 ARHGAP32 BIN1 SORBS2 RETREG2 PCLO CNTNAP1 NACA BRSK2 TACC2 SHANK3 PDHX NHSL1 DLGAP3 TJP1 SYN2 DLST PEAK1 WASF1 CEP170B AGAP2 | 2.87e-09 | 1139 | 134 | 21 | 36417873 | |
| Pubmed | BIN1 KMT2B SASH1 WIPF1 BICRA CNTNAP1 NFASC SHANK3 RYR1 DLGAP3 BAZ2A SOS1 | 6.32e-09 | 329 | 134 | 12 | 17474147 | |
| Pubmed | Targeted proteomic analysis of 14-3-3 sigma, a p53 effector commonly silenced in cancer. | 6.36e-09 | 102 | 134 | 8 | 15778465 | |
| Pubmed | The TRIM9/TRIM67 neuronal interactome reveals novel activators of morphogenesis. | ARHGAP32 SORBS2 PCLO NCKAP5L PRAG1 GRIP1 NHSL1 PEAK1 WASF1 CEP170B | 1.41e-08 | 218 | 134 | 10 | 33378226 |
| Pubmed | ZC3H14 KMT2B CDK12 SPTBN2 PTPN23 MPRIP KMT2C BAZ2A TJP1 YAP1 YLPM1 PEAK1 TAF6 PRRC2A | 3.06e-08 | 549 | 134 | 14 | 38280479 | |
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | ARHGAP32 SHROOM3 TMEM51 COBLL1 SPTBN2 MPRIP NHSL1 TBC1D10B TJP1 YAP1 NAV2 JPT1 PEAK1 PLEKHA7 | 4.36e-08 | 565 | 134 | 14 | 25468996 |
| Pubmed | KMT2B CDK12 SF3A1 COBLL1 WIPF3 CHD4 CIC WAC MPRIP PAPOLA YLPM1 DLST TAF6 | 8.97e-08 | 506 | 134 | 13 | 30890647 | |
| Pubmed | SHROOM3 SORBS2 AMER1 NCKAP5L GRIP1 TJP1 TBC1D22A YAP1 IRS2 MTCL1 PLEKHA7 CEP170B | 1.76e-07 | 446 | 134 | 12 | 24255178 | |
| Pubmed | ArgBP2-dependent signaling regulates pancreatic cell migration, adhesion, and tumorigenicity. | 2.23e-07 | 4 | 134 | 3 | 18559503 | |
| Pubmed | Comprehensive identification of phosphorylation sites in postsynaptic density preparations. | 3.06e-07 | 231 | 134 | 9 | 16452087 | |
| Pubmed | ARHGAP32 BAZ2B COBLL1 SPTBN2 BRSK2 PTPN23 MON1B SHANK3 WAC HIVEP3 SSH2 PEAK1 | 5.09e-07 | 493 | 134 | 12 | 15368895 | |
| Pubmed | DOCK4 SORBS2 PPRC1 SPEG ADAM9 DNAJC6 MAP7D1 BAZ2A MTCL1 SYVN1 CEP170B | 5.59e-07 | 407 | 134 | 11 | 12693553 | |
| Pubmed | CDK12 COBLL1 TACC2 WAC PTPN12 YAP1 MYPN NAV2 IRS2 MTCL1 TAF6 PRRC2A | 6.28e-07 | 503 | 134 | 12 | 16964243 | |
| Pubmed | ARHGAP32 TMEM51 SPTBN2 PTPN23 NCKAP5L CIC NHSL1 TBC1D10B PTPN12 BRD2 TJP1 YLPM1 SSH2 PEAK1 PLEKHA7 WASF1 PRRC2A | 6.41e-07 | 1049 | 134 | 17 | 27880917 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | ZC3H14 DEAF1 BAZ2B CDK12 BICRA SF3A1 CHD4 ZC3H18 CIC WAC BRD2 BAZ2A TJP1 YLPM1 TAF6 PRRC2A | 9.00e-07 | 954 | 134 | 16 | 36373674 |
| Pubmed | ARHGAP32 BIN1 SORBS2 CNTNAP1 NFASC SHANK3 GRIP1 DLGAP3 TBC1D10B CEP170B AGAP2 | 9.57e-07 | 430 | 134 | 11 | 32581705 | |
| Pubmed | BIN1 PCLO CNTNAP1 BRSK2 DNAJC6 SYN2 PRRC2A CEP170B AGAP2 SOS1 | 1.05e-06 | 347 | 134 | 10 | 17114649 | |
| Pubmed | ZC3H14 SHROOM3 INTS12 KMT2B CDK12 NACA CIC MPRIP SLC30A6 KMT2C MAP7D1 BRD2 AP1G1 BAZ2A EFHD1 CRACDL TAF6 PLEKHA7 PRRC2A CEP170B | 1.25e-06 | 1497 | 134 | 20 | 31527615 | |
| Pubmed | BIN1 SORBS2 PPRC1 ADAM9 SPTBN2 CNTNAP1 NR4A2 CHD4 WAC MPRIP BRD2 TJP1 YLPM1 DLST TAF6 PRRC2A AGAP2 SOS1 | 2.33e-06 | 1285 | 134 | 18 | 35914814 | |
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | CDK12 SF3A1 BRSK2 COL5A3 CHD4 PRAG1 MPRIP SLC30A6 PTK2B PTPN12 BRD2 ERRFI1 AFF1 MAP2K3 SOS1 | 2.49e-06 | 910 | 134 | 15 | 36736316 |
| Pubmed | TRERF1 ARHGAP32 DEAF1 INTS12 KMT2B BICRA NACA ZC3H18 CIC TFCP2 MPRIP KMT2C MAP7D1 BRD2 YAP1 YLPM1 ELK4 TAF6 PRRC2A | 2.55e-06 | 1429 | 134 | 19 | 35140242 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | ZC3H14 DEAF1 INTS12 KMT2B BAZ2B SF3A1 CHD4 ZC3H18 CIC TFCP2 WAC KMT2C MAP7D1 BRD2 BAZ2A YAP1 YLPM1 TAF6 | 2.57e-06 | 1294 | 134 | 18 | 30804502 |
| Pubmed | 2.74e-06 | 101 | 134 | 6 | 9872452 | ||
| Pubmed | Protein phosphatase 1γ isoforms linked interactions in the brain. | 2.81e-06 | 57 | 134 | 5 | 23080069 | |
| Pubmed | DOCK4 COL12A1 WIPF3 NR4A2 AGGF1 SHANK3 CIC TFCP2 NHSL1 KMT2C DLST MTCL1 SSH2 | 2.85e-06 | 689 | 134 | 13 | 36543142 | |
| Pubmed | 3.63e-06 | 233 | 134 | 8 | 29518331 | ||
| Pubmed | Large-scale phosphomimetic screening identifies phospho-modulated motif-based protein interactions. | 4.51e-06 | 110 | 134 | 6 | 37219487 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | SHROOM3 AMER1 BICRA DAB1 NFASC KLKP1 SPPL2B PLEKHG4B HIVEP3 KMT2C PPARGC1B TJP1 TBC1D22A EFHD1 ZFHX2 AFF1 ELK4 MAP2K3 CEP170B | 4.61e-06 | 1489 | 134 | 19 | 28611215 |
| Pubmed | TRERF1 ZC3H14 DEAF1 INTS12 KMT2B WIPF1 BAZ2B BICRA SF3A1 CHD4 CIC WAC KMT2C MAP7D1 TAF6 PRRC2A | 5.75e-06 | 1103 | 134 | 16 | 34189442 | |
| Pubmed | 6.27e-06 | 251 | 134 | 8 | 31076518 | ||
| Pubmed | BICRA CHD4 ZC3H18 NCKAP5L ENKD1 PDHX TBC1D10B ZNF469 MAP7D1 BRD2 BAZ2A SCN5A IRS2 TAF6 CEP170B SOS1 | 6.66e-06 | 1116 | 134 | 16 | 31753913 | |
| Pubmed | An inducible CRISPR/Cas9 screen identifies DTX2 as a transcriptional regulator of human telomerase. | 6.68e-06 | 180 | 134 | 7 | 35198878 | |
| Pubmed | SHROOM3 SASH1 CDK12 NACA MTSS1 NFASC BAHD1 KMT2C NBEAL2 NAV2 DEPDC5 | 6.94e-06 | 529 | 134 | 11 | 14621295 | |
| Pubmed | 7.90e-06 | 33 | 134 | 4 | 18271526 | ||
| Pubmed | 1.20e-05 | 12 | 134 | 3 | 35192416 | ||
| Pubmed | Identification of 14-3-3epsilon substrates from embryonic murine brain. | 1.29e-05 | 132 | 134 | 6 | 16944949 | |
| Pubmed | DOCK4 ZC3H14 ARHGAP32 BIN1 PRR36 SF3A1 NACA MPRIP PLEKHG4B MAP7D1 PEAK1 PLEKHA7 PRRC2A SOS1 | 1.29e-05 | 916 | 134 | 14 | 32203420 | |
| Pubmed | The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2. | ARHGAP32 ADAM9 TMEM51 SPTBN2 ARFGEF1 TBC1D10B NBEAL2 CRACDL NAV2 PEAK1 PLEKHA7 | 1.37e-05 | 569 | 134 | 11 | 30639242 |
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 34248958 | ||
| Pubmed | Homo- and Heterotypic Association Regulates Signaling by the SgK269/PEAK1 and SgK223 Pseudokinases. | 1.47e-05 | 2 | 134 | 2 | 27531744 | |
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 36469101 | ||
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 30504930 | ||
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 30697796 | ||
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 23796711 | ||
| Pubmed | Structure of SgK223 pseudokinase reveals novel mechanisms of homotypic and heterotypic association. | 1.47e-05 | 2 | 134 | 2 | 29079850 | |
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 32341238 | ||
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 28906292 | ||
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 31761670 | ||
| Pubmed | Capicua suppresses YAP1 to limit tumorigenesis and maintain drug sensitivity in human cancer. | 1.47e-05 | 2 | 134 | 2 | 36198276 | |
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 38474099 | ||
| Pubmed | Accumulation of Neurofascin at Nodes of Ranvier Is Regulated by a Paranodal Switch. | 1.47e-05 | 2 | 134 | 2 | 32554548 | |
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 35218185 | ||
| Pubmed | Genome-wide RNA interference screening reveals a COPI-MAP2K3 pathway required for YAP regulation. | 1.47e-05 | 2 | 134 | 2 | 32747557 | |
| Pubmed | Dynamin and PTP-PEST cooperatively regulate Pyk2 dephosphorylation in osteoclasts. | 1.47e-05 | 2 | 134 | 2 | 22342188 | |
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 20727793 | ||
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 28637666 | ||
| Pubmed | 1.55e-05 | 13 | 134 | 3 | 21406566 | ||
| Pubmed | WAVE1 is required for oligodendrocyte morphogenesis and normal CNS myelination. | 1.55e-05 | 13 | 134 | 3 | 16723544 | |
| Pubmed | Enoyl-CoA hydratase-1 regulates mTOR signaling and apoptosis by sensing nutrients. | 1.97e-05 | 14 | 134 | 3 | 28878358 | |
| Pubmed | ARHGAP32 SF3A1 TMEM51 COBLL1 PTPN23 ZC3H18 GRIP1 RABL6 TBC1D10B IRS2 PEAK1 PRRC2A | 2.03e-05 | 708 | 134 | 12 | 39231216 | |
| Pubmed | DEAF1 NR4A2 AGGF1 NR4A3 TACC2 CHD4 CIC KMT2C BRD2 BAZ2A ZFHX2 ELK4 | 2.06e-05 | 709 | 134 | 12 | 22988430 | |
| Pubmed | 2.44e-05 | 497 | 134 | 10 | 23414517 | ||
| Pubmed | TIF1beta/KAP-1 is a coactivator of the orphan nuclear receptor NGFI-B/Nur77. | 2.46e-05 | 15 | 134 | 3 | 19321449 | |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | DOCK4 ARHGAP32 SHROOM3 AMER1 SPTBN2 PTPN23 NCKAP5L TFCP2 PDHX GRIP1 TJP1 PLEKHA7 CEP170B | 2.74e-05 | 853 | 134 | 13 | 28718761 |
| Pubmed | 2.81e-05 | 403 | 134 | 9 | 30562941 | ||
| Pubmed | ARHGAP32 SASH1 TMEM51 MPRIP GRIP1 NHSL1 TBC1D10B PEAK1 PLEKHA7 | 3.94e-05 | 421 | 134 | 9 | 36976175 | |
| Pubmed | Dynamin-2 reduction rescues the skeletal myopathy of a SPEG-deficient mouse model. | 4.41e-05 | 3 | 134 | 2 | 35763354 | |
| Pubmed | NR4A nuclear receptors support memory enhancement by histone deacetylase inhibitors. | 4.41e-05 | 3 | 134 | 2 | 22996661 | |
| Pubmed | Inhibition of adipocyte differentiation by Nur77, Nurr1, and Nor1. | 4.41e-05 | 3 | 134 | 2 | 18945812 | |
| Pubmed | 4.41e-05 | 3 | 134 | 2 | 21454477 | ||
| Pubmed | 4.41e-05 | 3 | 134 | 2 | 31167787 | ||
| Pubmed | 4.41e-05 | 3 | 134 | 2 | 15964844 | ||
| Pubmed | 4.41e-05 | 3 | 134 | 2 | 25495651 | ||
| Pubmed | PIKE-mediated PI3-kinase activity is required for AMPA receptor surface expression. | 4.41e-05 | 3 | 134 | 2 | 21847098 | |
| Pubmed | 4.41e-05 | 3 | 134 | 2 | 19631450 | ||
| Pubmed | Macrophage fusion is controlled by the cytoplasmic protein tyrosine phosphatase PTP-PEST/PTPN12. | 4.41e-05 | 3 | 134 | 2 | 23589331 | |
| Pubmed | 4.41e-05 | 3 | 134 | 2 | 10523643 | ||
| Pubmed | FAK and PYK2 interact with SAP90/PSD-95-Associated Protein-3. | 4.41e-05 | 3 | 134 | 2 | 16202977 | |
| Pubmed | 4.41e-05 | 3 | 134 | 2 | 20659174 | ||
| Pubmed | 4.41e-05 | 3 | 134 | 2 | 36482877 | ||
| Pubmed | NR4A transcription factors limit CAR T cell function in solid tumours. | 4.41e-05 | 3 | 134 | 2 | 30814732 | |
| Pubmed | The NR4A orphan nuclear receptors: mediators in metabolism and diseases. | 4.41e-05 | 3 | 134 | 2 | 25089663 | |
| Pubmed | 4.41e-05 | 3 | 134 | 2 | 19465082 | ||
| Pubmed | 4.41e-05 | 3 | 134 | 2 | 15910281 | ||
| Pubmed | 4.41e-05 | 3 | 134 | 2 | 25899083 | ||
| Pubmed | WIP Drives Tumor Progression through YAP/TAZ-Dependent Autonomous Cell Growth. | 4.41e-05 | 3 | 134 | 2 | 27851961 | |
| Pubmed | 4.41e-05 | 3 | 134 | 2 | 9651378 | ||
| Pubmed | 4.41e-05 | 3 | 134 | 2 | 27159982 | ||
| Pubmed | The nuclear receptors NUR77, NURR1 and NOR1 in obesity and during fat loss. | 4.41e-05 | 3 | 134 | 2 | 22143616 | |
| Interaction | YWHAB interactions | DOCK4 ARHGAP32 BIN1 SHROOM3 SORBS2 SASH1 SPEG COBLL1 NCKAP5L TESK1 SHANK3 CIC TFCP2 GAB2 MPRIP GRIP1 NHSL1 SLC8A2 TBC1D10B MAP7D1 TJP1 TBC1D22A YAP1 ERRFI1 NAV2 SYN2 IRS2 MTCL1 SSH2 PEAK1 PLEKHA7 WASF1 CEP170B AGAP2 | 1.88e-15 | 1014 | 133 | 34 | int:YWHAB |
| Interaction | YWHAZ interactions | ARHGAP32 BIN1 SHROOM3 SORBS2 SASH1 SPEG COBLL1 SPTBN2 TACC2 ZC3H18 NCKAP5L SHANK3 CIC GAB2 MPRIP GRIP1 NHSL1 SLC8A2 MAP7D1 TJP1 YAP1 NBEAL2 ERRFI1 NAV2 SYN2 DLST DEPDC5 IRS2 SSH2 PEAK1 PLEKHA7 MAP2K3 WASF1 PRRC2A CEP170B GAREM1 | 1.25e-13 | 1319 | 133 | 36 | int:YWHAZ |
| Interaction | YWHAG interactions | DOCK4 ARHGAP32 SHROOM3 SORBS2 AMER1 SASH1 CDK12 SPEG COBLL1 NCKAP5L PRAG1 TESK1 SHANK3 CIC ENKD1 GAB2 MPRIP GRIP1 NHSL1 TBC1D10B MAP7D1 TJP1 YAP1 ERRFI1 NAV2 SYN2 DLST IRS2 MTCL1 SSH2 PEAK1 PLEKHA7 WASF1 CEP170B GAREM1 | 1.36e-13 | 1248 | 133 | 35 | int:YWHAG |
| Interaction | YWHAE interactions | ARHGAP32 SHROOM3 SORBS2 SASH1 CDK12 COBLL1 BRSK2 TACC2 ZC3H18 NCKAP5L PRAG1 SHANK3 CIC ENKD1 GAB2 MPRIP GRIP1 SLC8A2 DLGAP3 MAP7D1 PAPOLA YAP1 ERRFI1 NAV2 SYN2 DLST DEPDC5 IRS2 SSH2 PEAK1 PLEKHA7 WASF1 PRRC2A CEP170B GAREM1 | 1.64e-13 | 1256 | 133 | 35 | int:YWHAE |
| Interaction | YWHAH interactions | DOCK4 ZC3H14 ARHGAP32 SHROOM3 SORBS2 AMER1 INTS12 SASH1 SPEG COBLL1 NCKAP5L PRAG1 TESK1 CIC ENKD1 GAB2 MPRIP GRIP1 NHSL1 TBC1D10B MAP7D1 TJP1 YAP1 ERRFI1 NAV2 IRS2 MTCL1 SSH2 PEAK1 PLEKHA7 WASF1 CEP170B | 7.60e-13 | 1102 | 133 | 32 | int:YWHAH |
| Interaction | TOP3B interactions | SHROOM3 KMT2B ZNF628 PPRC1 CDK12 BICRA SPEG SPTBN2 POMGNT1 SPPL2B PRAG1 TESK1 BAHD1 CIC TFCP2 RYR1 MPRIP RABL6 HIVEP3 NHSL1 KMT2C BRD2 EFHD1 NBEAL2 SCN5A NAV2 DLST DEPDC5 IRS2 SYVN1 PRRC2A CEP170B GAREM1 | 3.02e-10 | 1470 | 133 | 33 | int:TOP3B |
| Interaction | YWHAQ interactions | ARHGAP32 SHROOM3 SORBS2 SASH1 SPEG COBLL1 NCKAP5L SHANK3 CIC TFCP2 ENKD1 GAB2 MPRIP GRIP1 NHSL1 SLC8A2 MAP7D1 TJP1 YAP1 ERRFI1 NAV2 DLST IRS2 SSH2 PEAK1 PLEKHA7 CEP170B GAREM1 | 8.01e-10 | 1118 | 133 | 28 | int:YWHAQ |
| Interaction | NCK2 interactions | FAM47A ARHGAP32 SORBS2 WIPF1 WIPF3 DAB1 NHSL1 PTPN12 YLPM1 PEAK1 WASF1 PRRC2A GAREM1 SOS1 | 2.15e-09 | 262 | 133 | 14 | int:NCK2 |
| Interaction | SFN interactions | ARHGAP32 SHROOM3 SORBS2 SASH1 COBLL1 ZC3H18 NCKAP5L GAB2 MPRIP GRIP1 MAP7D1 TJP1 YAP1 ERRFI1 NAV2 IRS2 SSH2 PEAK1 PLEKHA7 MAP2K3 CEP170B | 5.26e-09 | 692 | 133 | 21 | int:SFN |
| Interaction | KCTD13 interactions | ARHGAP32 BIN1 SORBS2 PRR36 PCLO SPTBN2 CNTNAP1 BRSK2 NFASC DNAJC6 SHANK3 PDHX MPRIP NHSL1 PTK2B SLC8A2 DLGAP3 MAP7D1 AP1G1 TJP1 CRACDL SYN2 DLST SSH2 PEAK1 PLEKHA7 WASF1 PRRC2A CEP170B AGAP2 | 6.23e-09 | 1394 | 133 | 30 | int:KCTD13 |
| Interaction | AGAP2 interactions | SORBS2 PCLO SPTBN2 PRAG1 SHANK3 MPRIP GRIP1 PTK2B DLGAP3 WASF1 CEP170B AGAP2 | 1.52e-08 | 210 | 133 | 12 | int:AGAP2 |
| Interaction | CRKL interactions | ARHGAP32 SASH1 WIPF1 DAB1 PRAG1 SHANK3 GAB2 WAC YAP1 PEAK1 GAREM1 SOS1 | 3.61e-08 | 227 | 133 | 12 | int:CRKL |
| Interaction | GRB2 interactions | DOCK4 ARHGAP32 WIPF1 WIPF3 PTPN23 PRAG1 SHANK3 GAB2 PTK2B PTPN12 BRD2 YLPM1 ERRFI1 IRS2 PEAK1 PLEKHA7 MAP2K3 WASF1 PRRC2A GAREM1 SOS1 | 7.25e-08 | 806 | 133 | 21 | int:GRB2 |
| Interaction | NCK1 interactions | ARHGAP32 WIPF1 WIPF3 DAB1 NFASC SHANK3 GAB2 NHSL1 PTPN12 YAP1 WASF1 SOS1 | 7.97e-08 | 244 | 133 | 12 | int:NCK1 |
| Interaction | DLGAP1 interactions | ARHGAP32 SORBS2 SPTBN2 CNTNAP1 DNAJC6 SHANK3 MPRIP DLGAP3 WASF1 AGAP2 | 3.29e-07 | 180 | 133 | 10 | int:DLGAP1 |
| Interaction | VASP interactions | SHROOM3 COBLL1 PTPN23 TFCP2 NHSL1 TBC1D10B XIRP2 TJP1 YAP1 IRS2 PEAK1 CEP170B | 5.92e-07 | 294 | 133 | 12 | int:VASP |
| Interaction | ACTC1 interactions | KMT2B WIPF1 CDK12 BICRA SF3A1 COBLL1 WIPF3 CHD4 CIC TFCP2 WAC MPRIP PAPOLA YAP1 YLPM1 ERRFI1 DLST TAF6 | 7.31e-07 | 694 | 133 | 18 | int:ACTC1 |
| Interaction | WASF1 interactions | 1.02e-06 | 116 | 133 | 8 | int:WASF1 | |
| Interaction | CRK interactions | ARHGAP32 SASH1 BICRA DAB1 PRAG1 GAB2 PTK2B YAP1 IRS2 PEAK1 WASF1 GAREM1 SOS1 | 1.07e-06 | 370 | 133 | 13 | int:CRK |
| Interaction | HOMER1 interactions | 4.19e-06 | 140 | 133 | 8 | int:HOMER1 | |
| Interaction | GRM3 interactions | 5.16e-06 | 18 | 133 | 4 | int:GRM3 | |
| Interaction | SYNGAP1 interactions | ARHGAP32 SORBS2 ADAM9 SPTBN2 CNTNAP1 SHANK3 PTK2B DLGAP3 DLST PEAK1 AGAP2 | 6.22e-06 | 307 | 133 | 11 | int:SYNGAP1 |
| Interaction | NAA40 interactions | ZC3H14 CDK12 SF3A1 NACA PTPN23 TACC2 CHD4 CIC TFCP2 WAC MPRIP PTPN12 PAPOLA BAZ2A TJP1 YLPM1 JPT1 IRS2 TAF6 PRRC2A | 6.48e-06 | 978 | 133 | 20 | int:NAA40 |
| Interaction | PPP1CC interactions | SORBS2 DEAF1 CDK12 TACC2 CHD4 ZC3H18 PRAG1 SHANK3 CIC ENKD1 MPRIP MAP7D1 SH3RF2 YAP1 MYPN YLPM1 PEAK1 | 7.43e-06 | 738 | 133 | 17 | int:PPP1CC |
| Interaction | SORBS2 interactions | 8.93e-06 | 111 | 133 | 7 | int:SORBS2 | |
| Interaction | ZYX interactions | ARHGAP32 SHROOM3 PTPN23 PLEKHG4B TBC1D10B PAPOLA TJP1 YAP1 SSH2 PEAK1 CEP170B | 1.19e-05 | 329 | 133 | 11 | int:ZYX |
| Interaction | PPP1R9B interactions | BIN1 SORBS2 PCLO SPTBN2 CNTNAP1 NACA BRSK2 DNAJC6 SHANK3 SLC8A2 DLGAP3 NAV2 SYN2 WASF1 AGAP2 | 1.68e-05 | 626 | 133 | 15 | int:PPP1R9B |
| Interaction | ABI1 interactions | 1.76e-05 | 223 | 133 | 9 | int:ABI1 | |
| Interaction | ACTB interactions | ARHGAP32 COBLL1 SPTBN2 WIPF3 DAB1 CHD4 PRRT2 TFCP2 MPRIP SLC30A6 NHSL1 TJP1 YAP1 EFHD1 ERRFI1 SYN2 ELK4 SSH2 PEAK1 WASF1 | 2.84e-05 | 1083 | 133 | 20 | int:ACTB |
| Interaction | SMARCB1 interactions | KMT2B BICRA SF3A1 SPTBN2 TACC2 CHD4 KMT2C BRD2 YAP1 DLST TAF6 | 3.03e-05 | 364 | 133 | 11 | int:SMARCB1 |
| Interaction | SLC6A4 interactions | ARHGAP32 BIN1 SORBS2 CNTNAP1 NFASC SHANK3 GRIP1 DLGAP3 TBC1D10B SYVN1 CEP170B AGAP2 | 3.35e-05 | 437 | 133 | 12 | int:SLC6A4 |
| Interaction | ACTG1 interactions | ARHGAP32 BIN1 SHROOM3 WIPF1 COBLL1 WIPF3 ZC3H18 PRRT2 PTPN12 YAP1 ERRFI1 ELK4 WASF1 | 4.12e-05 | 520 | 133 | 13 | int:ACTG1 |
| Interaction | PACSIN1 interactions | 4.74e-05 | 60 | 133 | 5 | int:PACSIN1 | |
| Interaction | CDH1 interactions | ARHGAP32 SHROOM3 ADAM9 TMEM51 COBLL1 SPTBN2 CHD4 MPRIP NHSL1 TBC1D10B TJP1 YAP1 NAV2 JPT1 PEAK1 PLEKHA7 | 4.75e-05 | 768 | 133 | 16 | int:CDH1 |
| Interaction | PEAK3 interactions | 5.92e-05 | 12 | 133 | 3 | int:PEAK3 | |
| Interaction | KCNA3 interactions | ARHGAP32 SF3A1 TMEM51 COBLL1 NACA PTPN23 ZC3H18 PRRT2 RYR1 MPRIP GRIP1 RABL6 KMT2C TBC1D10B IRS2 PEAK1 PRRC2A | 6.10e-05 | 871 | 133 | 17 | int:KCNA3 |
| Interaction | DYNLL2 interactions | 6.37e-05 | 263 | 133 | 9 | int:DYNLL2 | |
| Interaction | PLCG1 interactions | 6.56e-05 | 264 | 133 | 9 | int:PLCG1 | |
| Interaction | MYO1C interactions | SORBS2 SPTBN2 AGGF1 ZC3H18 TFCP2 MPRIP TJP1 YAP1 DLST ELK4 SYVN1 | 6.64e-05 | 397 | 133 | 11 | int:MYO1C |
| Interaction | CNKSR2 interactions | 7.51e-05 | 66 | 133 | 5 | int:CNKSR2 | |
| Interaction | SUPT5H interactions | INTS12 WIPF1 BICRA CHD4 ZC3H18 CIC WAC PAPOLA AIPL1 TAF6 MAP2K3 | 8.47e-05 | 408 | 133 | 11 | int:SUPT5H |
| Interaction | ACTN1 interactions | 9.04e-05 | 341 | 133 | 10 | int:ACTN1 | |
| Interaction | EFS interactions | 1.01e-04 | 37 | 133 | 4 | int:EFS | |
| Interaction | HOMER2 interactions | 1.01e-04 | 37 | 133 | 4 | int:HOMER2 | |
| Interaction | CTNNA1 interactions | ARHGAP32 SORBS2 SASH1 TFCP2 NHSL1 TJP1 YAP1 PEAK1 PLEKHA7 MAP2K3 | 1.04e-04 | 347 | 133 | 10 | int:CTNNA1 |
| Interaction | TAOK2 interactions | 1.10e-04 | 164 | 133 | 7 | int:TAOK2 | |
| Interaction | SHANK3 interactions | SORBS2 SPTBN2 CNTNAP1 NACA NFASC PRRT2 DNAJC6 SHANK3 DLGAP3 XIRP2 WASF1 AGAP2 | 1.12e-04 | 496 | 133 | 12 | int:SHANK3 |
| Interaction | TNR interactions | 1.12e-04 | 38 | 133 | 4 | int:TNR | |
| Interaction | BAZ2A interactions | 1.22e-04 | 73 | 133 | 5 | int:BAZ2A | |
| Interaction | WASL interactions | 1.27e-04 | 117 | 133 | 6 | int:WASL | |
| Interaction | ACTL6A interactions | 1.31e-04 | 289 | 133 | 9 | int:ACTL6A | |
| Interaction | XRCC6 interactions | BIN1 DEAF1 INTS12 CDK12 SF3A1 CNTNAP1 CHD4 ZC3H18 CIC TFCP2 PDHX WAC PAPOLA BAZ2A YAP1 YLPM1 DLST | 1.32e-04 | 928 | 133 | 17 | int:XRCC6 |
| Interaction | PTK2B interactions | 1.39e-04 | 119 | 133 | 6 | int:PTK2B | |
| Interaction | NRCAM interactions | 1.52e-04 | 41 | 133 | 4 | int:NRCAM | |
| Interaction | INA interactions | 1.53e-04 | 173 | 133 | 7 | int:INA | |
| Interaction | DNMBP interactions | 1.74e-04 | 124 | 133 | 6 | int:DNMBP | |
| Interaction | THRAP3 interactions | ZC3H14 CDK12 SF3A1 PCLO CHD4 ZC3H18 SHANK3 CIC YAP1 DLST ELK4 | 1.74e-04 | 443 | 133 | 11 | int:THRAP3 |
| Interaction | PNN interactions | 1.82e-04 | 302 | 133 | 9 | int:PNN | |
| Interaction | DLG4 interactions | DOCK4 ARHGAP32 SORBS2 CNTNAP1 SHANK3 PDHX PTK2B DLGAP3 SCN5A PEAK1 AGAP2 | 1.96e-04 | 449 | 133 | 11 | int:DLG4 |
| Interaction | RGS14 interactions | 1.96e-04 | 240 | 133 | 8 | int:RGS14 | |
| Interaction | DLGAP3 interactions | 2.01e-04 | 44 | 133 | 4 | int:DLGAP3 | |
| Interaction | PPP1CA interactions | SORBS2 DEAF1 NACA ZC3H18 CIC PDHX SH3RF2 YAP1 MYPN YLPM1 SYN2 IRS2 PEAK1 AGAP2 | 2.08e-04 | 696 | 133 | 14 | int:PPP1CA |
| Interaction | TNIK interactions | ARHGAP32 BIN1 SORBS2 SPTBN2 SHANK3 TJP1 WASF1 CEP170B AGAP2 SOS1 | 2.23e-04 | 381 | 133 | 10 | int:TNIK |
| Interaction | ATN1 interactions | 2.46e-04 | 187 | 133 | 7 | int:ATN1 | |
| Interaction | SH3KBP1 interactions | 2.48e-04 | 315 | 133 | 9 | int:SH3KBP1 | |
| Interaction | PITPNM1 interactions | 2.52e-04 | 19 | 133 | 3 | int:PITPNM1 | |
| Interaction | LCK interactions | ARHGAP32 COBLL1 SPTBN2 NCKAP5L GAB2 MPRIP SLC30A6 PTK2B PEAK1 PLEKHA7 SOS1 | 2.55e-04 | 463 | 133 | 11 | int:LCK |
| Interaction | TAF5 interactions | 2.64e-04 | 86 | 133 | 5 | int:TAF5 | |
| Interaction | GNAZ interactions | 2.78e-04 | 87 | 133 | 5 | int:GNAZ | |
| Interaction | GRAP interactions | 2.95e-04 | 20 | 133 | 3 | int:GRAP | |
| Interaction | YAP1 interactions | TRERF1 ZC3H14 KMT2B CDK12 SF3A1 SPTBN2 CHD4 TFCP2 MPRIP KMT2C BRD2 PAPOLA BAZ2A TJP1 YAP1 YLPM1 TAF6 PRRC2A | 3.14e-04 | 1095 | 133 | 18 | int:YAP1 |
| Interaction | FLOT1 interactions | ARHGAP32 SORBS2 PCLO SPTBN2 NCKAP5L TFCP2 TJP1 YAP1 DLST PEAK1 PLEKHA7 | 3.17e-04 | 475 | 133 | 11 | int:FLOT1 |
| Interaction | RAPGEF4 interactions | 3.30e-04 | 50 | 133 | 4 | int:RAPGEF4 | |
| Interaction | KLF8 interactions | 3.42e-04 | 329 | 133 | 9 | int:KLF8 | |
| Interaction | UQCR11 interactions | 4.13e-04 | 53 | 133 | 4 | int:UQCR11 | |
| Interaction | SMARCA5 interactions | 4.38e-04 | 415 | 133 | 10 | int:SMARCA5 | |
| Interaction | RHOB interactions | ARHGAP32 SHROOM3 AMER1 ADAM9 SPTBN2 BRSK2 NCKAP5L PDHX MPRIP TBC1D10B TJP1 IRS2 PEAK1 PLEKHA7 WASF1 | 4.38e-04 | 840 | 133 | 15 | int:RHOB |
| Interaction | SAA1 interactions | 4.44e-04 | 54 | 133 | 4 | int:SAA1 | |
| Interaction | SRC interactions | ARHGAP32 CNTNAP1 DAB1 PTPN23 CHD4 SHANK3 CIC GAB2 PTK2B PPARGC1B ERRFI1 AGAP2 SOS1 | 4.57e-04 | 664 | 133 | 13 | int:SRC |
| Interaction | PSTPIP1 interactions | 4.60e-04 | 97 | 133 | 5 | int:PSTPIP1 | |
| Interaction | PPP2R1A interactions | INTS12 CDK12 NACA PTPN23 ZC3H18 DNAJC6 CIC NHSL1 YAP1 DLST MTCL1 MAP2K3 AGAP2 | 4.64e-04 | 665 | 133 | 13 | int:PPP2R1A |
| Interaction | SMARCA2 interactions | 4.92e-04 | 346 | 133 | 9 | int:SMARCA2 | |
| Interaction | GSN interactions | 5.24e-04 | 212 | 133 | 7 | int:GSN | |
| Interaction | CHTOP interactions | 5.24e-04 | 212 | 133 | 7 | int:CHTOP | |
| Interaction | PFN1 interactions | DOCK4 COBLL1 PCLO WIPF3 ZC3H18 MPRIP NHSL1 TJP1 DLST PEAK1 WASF1 | 5.66e-04 | 509 | 133 | 11 | int:PFN1 |
| Interaction | NR1D1 interactions | 5.81e-04 | 25 | 133 | 3 | int:NR1D1 | |
| Interaction | NCKAP1 interactions | 6.19e-04 | 218 | 133 | 7 | int:NCKAP1 | |
| Interaction | SRGAP3 interactions | 6.23e-04 | 59 | 133 | 4 | int:SRGAP3 | |
| Interaction | DNM1 interactions | 6.38e-04 | 158 | 133 | 6 | int:DNM1 | |
| Interaction | NFASC interactions | 6.54e-04 | 26 | 133 | 3 | int:NFASC | |
| Interaction | RAPGEF2 interactions | 6.61e-04 | 105 | 133 | 5 | int:RAPGEF2 | |
| Interaction | SHC1 interactions | 6.80e-04 | 362 | 133 | 9 | int:SHC1 | |
| Cytoband | 22q13.3 | 1.26e-04 | 6 | 134 | 2 | 22q13.3 | |
| Cytoband | 11q13 | 4.12e-04 | 118 | 134 | 4 | 11q13 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2q24 | 5.43e-04 | 127 | 134 | 4 | chr2q24 | |
| Cytoband | 2q24.3 | 9.88e-04 | 16 | 134 | 2 | 2q24.3 | |
| GeneFamily | PHD finger proteins | 2.48e-06 | 90 | 78 | 6 | 88 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 2.94e-06 | 206 | 78 | 8 | 682 | |
| GeneFamily | PDZ domain containing | 4.99e-05 | 152 | 78 | 6 | 1220 | |
| GeneFamily | Zinc fingers CXXC-type|Methyl-CpG binding domain containing | 9.85e-04 | 11 | 78 | 2 | 1025 | |
| GeneFamily | Collagens | 1.03e-03 | 46 | 78 | 3 | 490 | |
| GeneFamily | Protein tyrosine phosphatases, non-receptor type | 2.69e-03 | 18 | 78 | 2 | 812 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | VGF DOCK4 RETREG2 SPEG PCLO MTSS1 BRSK2 ARFGEF1 NFASC PDZD7 PRRT2 DNAJC6 SHANK3 GRIP1 HIVEP3 SLC8A2 PPARGC1B SYN2 ZFHX2 SSH2 MAP2K3 WASF1 | 4.60e-08 | 1106 | 134 | 22 | M39071 |
| Coexpression | GSE14769_UNSTIM_VS_360MIN_LPS_BMDM_DN | CDK12 ARFGEF1 WAC SLC30A6 HIVEP3 KMT2C TBC1D10B SCN5A SYN2 AFF1 | 8.57e-08 | 200 | 134 | 10 | M3510 |
| Coexpression | LAKE_ADULT_KIDNEY_C22_ENDOTHELIAL_CELLS_GLOMERULAR_CAPILLARIES | 5.43e-07 | 137 | 134 | 8 | M39241 | |
| Coexpression | ZHONG_PFC_C3_ASTROCYTE | BIN1 PCLO SPTBN2 CNTNAP1 BRSK2 PRRT2 CIC GAB2 RABL6 BAZ2A AGAP2 | 5.38e-06 | 389 | 134 | 11 | M39102 |
| Coexpression | GSE14308_TH17_VS_NAIVE_CD4_TCELL_DN | 8.83e-06 | 199 | 134 | 8 | M3384 | |
| Coexpression | GSE43863_DAY6_EFF_VS_DAY150_MEM_TH1_CD4_TCELL_UP | 9.16e-06 | 200 | 134 | 8 | M9742 | |
| Coexpression | GSE17721_POLYIC_VS_CPG_16H_BMDC_UP | 9.16e-06 | 200 | 134 | 8 | M3950 | |
| Coexpression | GSE17721_POLYIC_VS_PAM3CSK4_1H_BMDC_DN | 9.16e-06 | 200 | 134 | 8 | M3826 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HDA1 | VGF DOCK4 NR4A2 NFASC PDZD7 PRRT2 DNAJC6 GAB2 HIVEP3 SLC8A2 ZFHX2 SSH2 WASF1 | 9.86e-06 | 584 | 134 | 13 | M39068 |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN | DOCK4 LRRC8C COL6A3 DEAF1 SASH1 BAZ2B SPEG TMEM51 NFASC CHD4 PRAG1 WAC NHSL1 TBC1D22A EFHD1 YLPM1 NAV2 WASF1 | 1.34e-05 | 1102 | 134 | 18 | M2369 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HNBGABA | VGF DOCK4 LRRC8C PCLO MTSS1 NFASC PDZD7 PRRT2 DNAJC6 SLC8A2 PPARGC1B SYN2 ZFHX2 CNGB1 | 1.55e-05 | 703 | 134 | 14 | M39070 |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN | DOCK4 LRRC8C COL6A3 DEAF1 SASH1 BAZ2B SPEG TMEM51 NFASC CHD4 PRAG1 WAC NHSL1 TBC1D22A EFHD1 YLPM1 NAV2 WASF1 | 1.75e-05 | 1124 | 134 | 18 | MM1070 |
| Coexpression | LAKE_ADULT_KIDNEY_C15_CONNECTING_TUBULE | 2.91e-05 | 171 | 134 | 7 | M39234 | |
| Coexpression | LAKE_ADULT_KIDNEY_C17_COLLECTING_SYSTEM_PCS_STRESSED_DISSOC_SUBSET | 3.40e-05 | 240 | 134 | 8 | M39236 | |
| Coexpression | BILD_HRAS_ONCOGENIC_SIGNATURE | 4.80e-05 | 252 | 134 | 8 | M12029 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HDA | DOCK4 BIN1 NR4A2 PDZD7 PRRT2 GRIP1 HIVEP3 PTK2B SLC8A2 ZFHX2 CNGB1 | 6.06e-05 | 506 | 134 | 11 | M39067 |
| Coexpression | IVANOVA_HEMATOPOIESIS_STEM_CELL | 6.28e-05 | 193 | 134 | 7 | M6813 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HDA2 | VGF DEAF1 NR4A2 NFASC PDZD7 TACC2 PRRT2 DNAJC6 SLC8A2 SYN2 JPT1 | 6.85e-05 | 513 | 134 | 11 | M39069 |
| Coexpression | IVANOVA_HEMATOPOIESIS_STEM_CELL | 6.92e-05 | 196 | 134 | 7 | MM667 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C1_GHRL_POS_NE_PRECURSOR_CELL | VGF ARHGAP32 COL12A1 TMEM51 PCLO SPTBN2 TESK1 BAHD1 ZFHX2 WASF1 | 7.46e-05 | 429 | 134 | 10 | M45694 |
| Coexpression | HALLMARK_MITOTIC_SPINDLE | 7.61e-05 | 199 | 134 | 7 | M5893 | |
| Coexpression | GSE15324_NAIVE_VS_ACTIVATED_CD8_TCELL_UP | 7.86e-05 | 200 | 134 | 7 | M3523 | |
| Coexpression | GSE46606_DAY1_VS_DAY3_CD40L_IL2_IL5_STIMULATED_IRF4_KO_BCELL_UP | 7.86e-05 | 200 | 134 | 7 | M9825 | |
| Coexpression | LAKE_ADULT_KIDNEY_C16_COLLECTING_SYSTEM_PRINCIPAL_CELLS_CORTEX | 8.89e-05 | 141 | 134 | 6 | M39235 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HSERT | 1.10e-04 | 450 | 134 | 10 | M39072 | |
| Coexpression | LAKE_ADULT_KIDNEY_C2_PODOCYTES | 1.13e-04 | 212 | 134 | 7 | M39221 | |
| Coexpression | PHONG_TNF_RESPONSE_VIA_P38_COMPLETE | 1.59e-04 | 224 | 134 | 7 | M2500 | |
| Coexpression | OUYANG_PROSTATE_CANCER_PROGRESSION_DN | 1.62e-04 | 21 | 134 | 3 | MM756 | |
| Coexpression | OUYANG_PROSTATE_CANCER_PROGRESSION_DN | 1.62e-04 | 21 | 134 | 3 | M14636 | |
| Coexpression | GSE6269_FLU_VS_E_COLI_INF_PBMC_UP | 2.03e-04 | 164 | 134 | 6 | M5653 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_ACTC_POS_SMC_CELL | DEAF1 SPEG TMEM51 NR4A3 TACC2 GAB2 PLEKHG4B ERRFI1 NAV2 MTCL1 WASF1 | 2.29e-04 | 589 | 134 | 11 | M45662 |
| CoexpressionAtlas | dev gonad_e12.5_M_DevVasTestis_Flk_top-relative-expression-ranked_1000 | DOCK4 LRRC8C MRC1 BIN1 SORBS2 SASH1 WIPF1 MTSS1 NR4A2 PRAG1 SHANK3 SMTN NHSL1 PTPN12 TJP1 SSH2 MADCAM1 | 2.25e-05 | 847 | 133 | 17 | gudmap_dev gonad_e12.5_M_gudmap_devVasTestis_Flk_1000 |
| CoexpressionAtlas | dev gonad_e12.5_F_DevVasOvary_Flk_top-relative-expression-ranked_1000 | DOCK4 LRRC8C MRC1 SORBS2 SASH1 WIPF1 MTSS1 NR4A2 PRAG1 SHANK3 SMTN NHSL1 PTPN12 TJP1 SSH2 MADCAM1 | 5.34e-05 | 817 | 133 | 16 | gudmap_dev gonad_e12.5_F_gudmap_devVasOvary_Flk_1000 |
| CoexpressionAtlas | dev gonad_e11.5_F_ReproVasc_Flk_top-relative-expression-ranked_1000 | DOCK4 LRRC8C MRC1 BIN1 SASH1 WIPF1 MTSS1 NR4A2 SHANK3 SMTN NHSL1 PTPN12 TJP1 SSH2 PEAK1 MADCAM1 | 5.34e-05 | 817 | 133 | 16 | gudmap_dev gonad_e11.5_F_ReproVasc_Flk_1000 |
| CoexpressionAtlas | dev gonad_e13.5_F_DevVascOvary_Flk_top-relative-expression-ranked_1000 | DOCK4 LRRC8C MRC1 BIN1 SORBS2 SASH1 WIPF1 MTSS1 SHANK3 SMTN NHSL1 PTPN12 TJP1 SSH2 PEAK1 MADCAM1 | 6.52e-05 | 831 | 133 | 16 | gudmap_dev gonad_e13.5_F_gudmap_devVascOvary_Flk_1000 |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.84e-10 | 193 | 134 | 10 | be28070c049e7cb68bcd54f582226eb2f5e4bc1c | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.84e-10 | 193 | 134 | 10 | 0c652ebe22ce5d2927599dd97ef1920547858395 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.84e-10 | 193 | 134 | 10 | 8689a70a33a7c3823dc647d41ac0160e7c3ae396 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | SHROOM3 SORBS2 TACC2 GRIP1 PLEKHG4B SH3RF2 ERRFI1 NAV2 MTCL1 | 3.88e-09 | 179 | 134 | 9 | 04ce3673e46606f63d9c87bcba3a64c96817d812 |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.43e-09 | 186 | 134 | 9 | bd1185592aedebccd1007dbf2dd2f549fcdf9f42 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | SHROOM3 SORBS2 TACC2 PLEKHG4B SH3RF2 ERRFI1 NAV2 MTCL1 PLEKHA7 | 5.43e-09 | 186 | 134 | 9 | 4e94158db52df41d71e67b02b9895a358eebee0f |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m-Epithelial|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.25e-09 | 189 | 134 | 9 | 965e0e388251e7318f8b463816dc96ccb4658677 | |
| ToppCell | Hippocampus-Neuronal-Excitatory|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 6.25e-09 | 189 | 134 | 9 | 4b90d181eb0a42814eeb23bc82e52fd3a12392a7 | |
| ToppCell | Parenchymal-NucSeq|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations | 9.37e-09 | 198 | 134 | 9 | 1996373bdccc55aac347d349bd22f6aad6d0c668 | |
| ToppCell | Bronchial-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | ARHGAP32 SHROOM3 SORBS2 COBLL1 TACC2 NHSL1 YAP1 PLEKHA7 GAREM1 | 9.79e-09 | 199 | 134 | 9 | 5f7da3eab58ace6cddb3179a415cd839d5767958 |
| ToppCell | Parenchymal-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | ARHGAP32 SHROOM3 SORBS2 COBLL1 TACC2 NHSL1 YAP1 PLEKHA7 GAREM1 | 9.79e-09 | 199 | 134 | 9 | 5cea0d9e261903e0eaad60c28a07dff72ce65027 |
| ToppCell | Tracheal-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | ARHGAP32 SHROOM3 SORBS2 PCLO TACC2 GRIP1 CRACDL PLEKHA7 GAREM1 | 1.02e-08 | 200 | 134 | 9 | d3af0a706baf66e3f32e67b17dcfc31e5b32ce0e |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.58e-08 | 147 | 134 | 8 | 8f725ff8fb4ced5db2643e80669d3f7945b820ab | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_3|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.99e-08 | 178 | 134 | 8 | 5d6297f34e104bacefb25c4e2338b50fe13dd19a | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-24m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.02e-07 | 187 | 134 | 8 | e04a84989d624378141042768383b9c846901f2d | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-24m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.02e-07 | 187 | 134 | 8 | 24cc03c748e15f7ef0e6509ca5a6ca583fb9c573 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-24m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.02e-07 | 187 | 134 | 8 | 2f153b203fe79f206319603cf94d3a03ab49a05d | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.06e-07 | 188 | 134 | 8 | 43a3a59f92ad93509d4166bd025aed0b1b39a008 | |
| ToppCell | Adult-Epithelial|Adult / Lineage, Cell type, age group and donor | 1.25e-07 | 192 | 134 | 8 | efb962a5fd3b9bdfd8cf8d13c435e29c8271713e | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.30e-07 | 193 | 134 | 8 | 3866667dd221612589ae50f5c52f73a183a49ce6 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.35e-07 | 194 | 134 | 8 | 46070fbb0ee0eb9e1801c43b73a15707471056dc | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.35e-07 | 194 | 134 | 8 | abacb6a8d7a9003f2f6c2be0305507f1c1c50347 | |
| ToppCell | Bronchial-NucSeq|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations | 1.47e-07 | 196 | 134 | 8 | ab53c742866945545a92e2e61850d63c80d9a2a6 | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 1.65e-07 | 199 | 134 | 8 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN1(Slc17a7)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 7.87e-07 | 168 | 134 | 7 | 6db453cbbbaf4144a86fadcfa5805d33396713b5 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_3-Exc_L2-3_LINC00507_RPL9P17|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.07e-06 | 176 | 134 | 7 | 07abf29d681abdd6c7cc87f9eaf9377e92ce212c | |
| ToppCell | facs-Marrow-B-cells-3m-Lymphocytic-early_pro_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.07e-06 | 176 | 134 | 7 | 29cda51a99100ddd2928cadc92da40f001d7e1f4 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_3-Exc_L2-3_LINC00507_RPL9P17|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.07e-06 | 176 | 134 | 7 | c7be4eaa5eb76ad9389fb9d15ad0934e88d267d1 | |
| ToppCell | facs-Marrow-B-cells-3m-Lymphocytic-early_pro-B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.07e-06 | 176 | 134 | 7 | 01774a86d7d92f31a056b753f9844f923038003e | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_3|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.12e-06 | 177 | 134 | 7 | 8b003ed7887479c3a010ef37dd981b748256bda7 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.16e-06 | 178 | 134 | 7 | a74e5a390cbeaca9de1fdb7b2a0e50783bd202dd | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.16e-06 | 178 | 134 | 7 | 1bddbc083c36657bd6910f7466126ab325e88176 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.20e-06 | 179 | 134 | 7 | a3922476f33d2e4137a12dbda21a1703dff79684 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.30e-06 | 181 | 134 | 7 | 5bf7aa43f6e6ecce15c95928b91195544d6928c4 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.30e-06 | 181 | 134 | 7 | 8e751f5d7cd2d328ec0196d874e8a507e8c4e1a9 | |
| ToppCell | COVID-19-Epithelial_cells-ECM-high_epithelial|COVID-19 / group, cell type (main and fine annotations) | 1.39e-06 | 183 | 134 | 7 | dc1d380bf7564f290256cb7108063d1bd2da732b | |
| ToppCell | COVID-19-lung-AT1|lung / Disease (COVID-19 only), tissue and cell type | 1.39e-06 | 183 | 134 | 7 | 942530449e9c6583705eeb8f6f12621daea57252 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_3-Exc_L2-3_LINC00507_RPL9P17|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.39e-06 | 183 | 134 | 7 | 1645d4a55cd8c22d6eb47fc5c6b1e576c454f111 | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.45e-06 | 184 | 134 | 7 | 25ccf08a8a26d7e7827b6357f33a53aaf423577d | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_3|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.45e-06 | 184 | 134 | 7 | 34e316ad8e7b8667cd8ad61397281802a252744f | |
| ToppCell | droplet-Fat-Scat-21m-Mesenchymal-Cd34+|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.50e-06 | 185 | 134 | 7 | 01bbe1e09f9ccae837a03ea2cdd168fa10800942 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.50e-06 | 185 | 134 | 7 | a0a629e5d2b65f670ea907bd3f5e3caf17687d8f | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Neuronal-neurons_B-Branch_B3_(IPAN)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.50e-06 | 185 | 134 | 7 | edb114487206e4e8df4c7878285df40f49b7fd64 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.55e-06 | 186 | 134 | 7 | 3aebe163799109ffc67e4e10ee47c2dd0886a92c | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.61e-06 | 187 | 134 | 7 | d4b0afd9b92c47c8aa348bbd1af7eb54c3d478f2 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.67e-06 | 188 | 134 | 7 | 4bdf8d49af0e9da349b16e3f012e1b0eec04cc4f | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.79e-06 | 190 | 134 | 7 | 30b50d183d7649146eb1e79b47ba897355f1998a | |
| ToppCell | LV-01._Fibroblast_I|World / Chamber and Cluster_Paper | 1.79e-06 | 190 | 134 | 7 | 12992ec80a7b4f4f17de693f0719ee061a9918fd | |
| ToppCell | Epithelial|World / Lineage, Cell type, age group and donor | 1.92e-06 | 192 | 134 | 7 | 499e8893afea5e6d3371e0bd018f7e86a524d669 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.92e-06 | 192 | 134 | 7 | cc9911e182a289779a2612bc213daae5607689e7 | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_adipo-stroma|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.99e-06 | 193 | 134 | 7 | cf2461af78f65616ce40d552ee9452295e3895ed | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_adipo|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.99e-06 | 193 | 134 | 7 | 6ef9007c9d18fb775d08fb20cdf954a28d54d7eb | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.99e-06 | 193 | 134 | 7 | 82e8a4c40299ffcdfd5a0da711bb9de6fb8a2eaa | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_adipo-stroma-adipo-CAR|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.99e-06 | 193 | 134 | 7 | e4ea7ce011a80b81b841c907719aa532bed39d2e | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.06e-06 | 194 | 134 | 7 | 93c68c31e39fa44c1d05d7d4997f4f086da4e738 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.06e-06 | 194 | 134 | 7 | 5eaaa81f4b2535f983c424aaef00077089526a5c | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_myocytic|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.06e-06 | 194 | 134 | 7 | 67f5e2f05a8de2213ab80d5ea16fdee121684633 | |
| ToppCell | Control-Multiplet|Control / Disease state, Lineage and Cell class | 2.13e-06 | 195 | 134 | 7 | 618900c80bea09d46dad3f741bd1bff8bf0a64ee | |
| ToppCell | facs-Mammary_Gland|facs / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.13e-06 | 195 | 134 | 7 | 21cfcb751e548591fc8724a8329c294da6012e0f | |
| ToppCell | Control-Multiplet-Multiplet|Control / Disease state, Lineage and Cell class | 2.13e-06 | 195 | 134 | 7 | 06ac685855e14e4dd2cbe6d0e73f894f2eeff91f | |
| ToppCell | Striatum-Neuronal-Excitatory|Striatum / BrainAtlas - Mouse McCarroll V32 | 2.20e-06 | 196 | 134 | 7 | 67400193ba469cf4d939e94f5ed94995e384bc07 | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_adipo-stroma-adipo-CAR|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.35e-06 | 198 | 134 | 7 | a8c21f4db6730d0aa05b61fbe72bf9f7571a9015 | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_adipo-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.35e-06 | 198 | 134 | 7 | 8b68fc887e5ad0a59ea4d93dfd1edda67030f142 | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_adipo|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.35e-06 | 198 | 134 | 7 | 4739b2e4ab141c66772e61686b45614a1839483e | |
| ToppCell | Neuronal-Excitatory-eA(LAMP5_LINC00507)-FREM3---L2-3|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.52e-06 | 200 | 134 | 7 | 9c89e91bb630cc306a820927a36ea6fb3d13e9d7 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-5w-Neuronal-Intermediate|5w / Sample Type, Dataset, Time_group, and Cell type. | 2.52e-06 | 200 | 134 | 7 | c92e4fc0442404481fcac623d691dae6215b852d | |
| ToppCell | Neuronal-Excitatory-eA(LAMP5_LINC00507)-FREM3-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.52e-06 | 200 | 134 | 7 | 8821574d17b55dfea3ca0204e6b4c0ca6b19588a | |
| ToppCell | Neuronal-Excitatory-eA(LAMP5_LINC00507)-FREM3--|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.52e-06 | 200 | 134 | 7 | 96b1d2e70fbbba744fd4356a70efcf356aca9abc | |
| ToppCell | distal-mesenchymal-Airway_Smooth_Muscle|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.52e-06 | 200 | 134 | 7 | 1b5ac5b3ddd4df32e940531cc020998f8cd95c2c | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_submucosal-gland|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.52e-06 | 200 | 134 | 7 | 0eb9ad8c0373bcc62029ec21c590ed03aaacd039 | |
| ToppCell | Neuronal-Excitatory-eA(LAMP5_LINC00507)-FREM3|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.52e-06 | 200 | 134 | 7 | ad6f1d4d7f5d7bab2ba2e4fff58c535290065c0e | |
| ToppCell | Globus_pallidus-Neuronal-Excitatory|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 9.08e-06 | 160 | 134 | 6 | f843287ed57d2d5a3b3f6dfb03b6934e330e6645 | |
| ToppCell | droplet-Marrow-nan-18m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.41e-06 | 161 | 134 | 6 | 3f3a2148c8d65e6a06f8d8116a3aa58dda17d618 | |
| ToppCell | Globus_pallidus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 9.41e-06 | 161 | 134 | 6 | ebcd5066e82b7760b9da6adc02d11258d1309dab | |
| ToppCell | facs-Spleen-nan-3m-Hematologic|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.41e-06 | 161 | 134 | 6 | 45591addc765760db6029ac19e80573373d1d917 | |
| ToppCell | facs-Spleen-nan-3m-Hematologic-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.41e-06 | 161 | 134 | 6 | 8741b91a62c9a8ce377ef6533d323b65beb93c63 | |
| ToppCell | facs-Spleen-nan-3m-Hematologic-proerythroblast|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.41e-06 | 161 | 134 | 6 | 9cf1dcf0e7ca9e35c46c094a6b78f98d1f6b9276 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-club_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 9.75e-06 | 162 | 134 | 6 | 5c9bc3c3857a99d8a3caf359a7eb279ce9cc1c81 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Macula_Densa_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 9.75e-06 | 162 | 134 | 6 | 373513f9d0e5007b2e10a8b78d4909dcce9e3b62 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Neuronal-SPN_Neuron_STR|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.08e-05 | 165 | 134 | 6 | 1b7dfa173e83aa8c46a3153a3261866c065c3b73 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Neuronal-medium_spiny_neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.08e-05 | 165 | 134 | 6 | b4f7d33af7d053ec07b01bd67d861600a9c4822e | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.28e-05 | 170 | 134 | 6 | fa753cc8fbd04e63c9a303da4dc17ee2ce907f92 | |
| ToppCell | wk_08-11-Mesenchymal-Myofibro_&_SMC-Myofibro_2|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.28e-05 | 170 | 134 | 6 | fefb07a7e308b620f946b9ff2b01e1796446fe38 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.28e-05 | 170 | 134 | 6 | 03044e1436443b28dd39d5ef4fdb25c18e3a7546 | |
| ToppCell | Control-Epithelial_cells-ECM-high_epithelial|Control / group, cell type (main and fine annotations) | 1.28e-05 | 170 | 134 | 6 | e2023d66e70983c87dacbd6181d3426488d1fc57 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.33e-05 | 171 | 134 | 6 | 1854a777d9eb9d3fc3ed3632332a6f89ce8131da | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell_prolif|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.42e-05 | 173 | 134 | 6 | f193c63cc536d891c9d23043765e320252bb6e65 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.61e-05 | 177 | 134 | 6 | 4d2cdb57b427a42085c5f9affa0967b15e84dec3 | |
| ToppCell | Control-Epithelial_alveolar-AT_1-Differentiating_AT1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.61e-05 | 177 | 134 | 6 | 9af14a056eb6d88c6f11b09f6d4c0d3448d647d5 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.66e-05 | 178 | 134 | 6 | edc7143dc9959d36057cb9471681a23afcbc8cce | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_3|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.66e-05 | 178 | 134 | 6 | ccea3c8908d72f5fecd151a133048c8e9758304c | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_3-Exc_L2-3_LINC00507_RPL9P17|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.72e-05 | 179 | 134 | 6 | 9ba8693fba2175bca9ff9735cc04e657abeb9084 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.83e-05 | 181 | 134 | 6 | b45b11428d13950369347e051d4d517efb2bd4fd | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)-Exc_L2-4_RORB_GRIK1|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.83e-05 | 181 | 134 | 6 | 57994ff4ecffb15653aee00644d9f887f5e3461d | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Neuronal-medium_spiny_neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.89e-05 | 182 | 134 | 6 | d41ff834b8fc1d0e23cac7ae261de5f72874e462 | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-SM_activated_stress_response-SM_activated_stress_response_L.2.3.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.89e-05 | 182 | 134 | 6 | 97bb07478f56a937b490fba121ee603db64134a1 | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-SM_activated_stress_response|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.89e-05 | 182 | 134 | 6 | 1c1a687f728341c209b048b6715bcddd0ac20069 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Neuronal-SPN_Neuron_STR|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.89e-05 | 182 | 134 | 6 | 6cde859edfe7607bd7ada89d20258413d06f4207 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-Mes-Like-Differentiating_AT1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.90e-05 | 108 | 134 | 5 | d620f07243c2628494e689bbfabc14c453f4b1f4 | |
| ToppCell | IPF-Epithelial-ATI|World / Disease state, Lineage and Cell class | 1.95e-05 | 183 | 134 | 6 | 31fef35ecf30162662f24d335d8f0cceacc07039 | |
| Drug | Nitrendipine [39562-70-4]; Up 200; 11uM; HL60; HT_HG-U133A | 1.98e-06 | 192 | 133 | 9 | 3087_UP | |
| Drug | Pizotifen malate [5189-11-7]; Down 200; 9.4uM; MCF7; HT_HG-U133A | 2.16e-06 | 194 | 133 | 9 | 5491_DN | |
| Drug | Tyloxapol [25301-02-4]; Down 200; 4uM; MCF7; HT_HG-U133A | 2.55e-06 | 198 | 133 | 9 | 6452_DN | |
| Drug | Asbestos, Crocidolite | TRERF1 VGF DOCK4 LRRC8C COL12A1 KMT2B SASH1 TMEM51 NR4A2 NR4A3 GRIP1 HIVEP3 NHSL1 PPARGC1B TJP1 YAP1 MYPN NAV2 IRS2 ELK4 MAP2K3 SOS1 | 2.98e-06 | 1241 | 133 | 22 | ctd:D017638 |
| Drug | Chelidonine monohydrate (+) [476-32-4]; Up 200; 10.8uM; HL60; HG-U133A | 3.67e-06 | 155 | 133 | 8 | 1786_UP | |
| Drug | Mometasone furoate [83919-23-7]; Up 200; 7.6uM; HL60; HG-U133A | 8.99e-06 | 175 | 133 | 8 | 1746_UP | |
| Drug | LY 294002; Up 200; 10uM; PC3; HT_HG-U133A | 1.15e-05 | 181 | 133 | 8 | 1236_UP | |
| Drug | fluphenazine dihydrochloride; Up 200; 10uM; MCF7; HT_HG-U133A | 1.57e-05 | 189 | 133 | 8 | 6954_UP | |
| Drug | Bepridil hydrochloride [74764-40-2]; Up 200; 10uM; MCF7; HT_HG-U133A | 1.63e-05 | 190 | 133 | 8 | 2629_UP | |
| Drug | MS-275; Down 200; 10uM; PC3; HT_HG-U133A | 1.83e-05 | 193 | 133 | 8 | 7084_DN | |
| Drug | Enilconazole [35554-44-0]; Down 200; 13.4uM; MCF7; HT_HG-U133A | 1.90e-05 | 194 | 133 | 8 | 6518_DN | |
| Drug | LY 294002; Down 200; 10uM; MCF7; HT_HG-U133A_EA | 1.97e-05 | 195 | 133 | 8 | 1007_DN | |
| Drug | Oxprenolol hydrochloride [6452-73-9]; Down 200; 13.2uM; MCF7; HT_HG-U133A | 1.97e-05 | 195 | 133 | 8 | 7225_DN | |
| Drug | Deptropine citrate [2169-75-7]; Up 200; 7.6uM; HL60; HT_HG-U133A | 2.04e-05 | 196 | 133 | 8 | 3144_UP | |
| Drug | DNA-PK Inhibitor III; Down 200; 1uM; MCF7; HT_HG-U133A | 2.04e-05 | 196 | 133 | 8 | 7513_DN | |
| Drug | Butylparaben [94-26-8]; Down 200; 20.6uM; HL60; HT_HG-U133A | 2.04e-05 | 196 | 133 | 8 | 3069_DN | |
| Drug | 2-propylpentanoic acid; Down 200; 50uM; PC3; HT_HG-U133A | 2.04e-05 | 196 | 133 | 8 | 4446_DN | |
| Drug | Acetaminophen [103-90-2]; Down 200; 26.4uM; MCF7; HT_HG-U133A | 2.12e-05 | 197 | 133 | 8 | 3364_DN | |
| Drug | Doxazosin mesylate [77883-43-3]; Down 200; 7.4uM; MCF7; HT_HG-U133A | 2.12e-05 | 197 | 133 | 8 | 4988_DN | |
| Drug | Streptomycin sulfate [3810-74-0]; Down 200; 2.8uM; MCF7; HT_HG-U133A | 2.12e-05 | 197 | 133 | 8 | 7194_DN | |
| Drug | Triamterene [396-01-0]; Down 200; 15.8uM; MCF7; HT_HG-U133A | 2.12e-05 | 197 | 133 | 8 | 1697_DN | |
| Drug | Guanabenz acetate [23256-50-0]; Up 200; 13.8uM; MCF7; HT_HG-U133A | 2.20e-05 | 198 | 133 | 8 | 1544_UP | |
| Drug | Iopamidol [60166-93-0]; Down 200; 5.2uM; MCF7; HT_HG-U133A | 2.20e-05 | 198 | 133 | 8 | 7189_DN | |
| Drug | Tetrandrine [518-34-3]; Down 200; 6.4uM; MCF7; HT_HG-U133A | 2.20e-05 | 198 | 133 | 8 | 7178_DN | |
| Drug | Novobiocin sodium salt [1476-53-5]; Up 200; 6.4uM; MCF7; HT_HG-U133A | 2.20e-05 | 198 | 133 | 8 | 4392_UP | |
| Drug | Benserazide hydrochloride [14919-77-8]; Down 200; 13.6uM; MCF7; HT_HG-U133A | 2.20e-05 | 198 | 133 | 8 | 6482_DN | |
| Drug | Calciferol [50-14-6]; Down 200; 10uM; HL60; HT_HG-U133A | 2.28e-05 | 199 | 133 | 8 | 2442_DN | |
| Drug | CP-690334-01 [459212-38-5]; Down 200; 1uM; MCF7; HT_HG-U133A | 2.28e-05 | 199 | 133 | 8 | 4383_DN | |
| Drug | Dimaprit dihydrochloride [23256-33-9]; Down 200; 17uM; MCF7; HT_HG-U133A | 2.36e-05 | 200 | 133 | 8 | 6520_DN | |
| Drug | Isometheptene mucate; Up 200; 8.2uM; MCF7; HT_HG-U133A | 2.36e-05 | 200 | 133 | 8 | 5502_UP | |
| Drug | forskolin; Up 200; 50uM; MCF7; HT_HG-U133A_EA | 3.90e-05 | 157 | 133 | 7 | 913_UP | |
| Drug | polyproline | 6.10e-05 | 295 | 133 | 9 | CID000439587 | |
| Drug | Dipivefrin hydrochloride [64019-93-8]; Up 200; 10.4uM; HL60; HG-U133A | 9.25e-05 | 180 | 133 | 7 | 1752_UP | |
| Drug | Lynestrenol [52-76-6]; Up 200; 14uM; MCF7; HT_HG-U133A | 9.57e-05 | 181 | 133 | 7 | 1537_UP | |
| Drug | Papaverine hydrochloride [61-25-6]; Up 200; 10.6uM; HL60; HG-U133A | 9.91e-05 | 182 | 133 | 7 | 1755_UP | |
| Drug | Betamethasone [378-44-9]; Up 200; 10.2uM; HL60; HG-U133A | 1.03e-04 | 183 | 133 | 7 | 1590_UP | |
| Drug | bromfenacoum | SF3A1 CNTNAP1 NACA MTSS1 ZC3H18 DNAJC6 MPRIP NHSL1 SLC8A2 TJP1 YAP1 WASF1 CEP170B | 1.05e-04 | 644 | 133 | 13 | ctd:C013418 |
| Drug | Rescinnamin [24815-24-5]; Up 200; 6.4uM; HL60; HT_HG-U133A | 1.13e-04 | 186 | 133 | 7 | 2130_UP | |
| Drug | AC1L9MVH | 1.25e-04 | 17 | 133 | 3 | CID000449220 | |
| Drug | forskolin; Down 200; 50uM; MCF7; HT_HG-U133A_EA | 1.25e-04 | 189 | 133 | 7 | 913_DN | |
| Drug | DMSe | 1.27e-04 | 132 | 133 | 6 | CID000020796 | |
| Drug | colcemid; Up 200; 11.7uM; MCF7; HT_HG-U133A_EA | 1.30e-04 | 190 | 133 | 7 | 1103_UP | |
| Drug | mono-(2-ethylhexyl)phthalate | SORBS2 COL12A1 BICRA SPTBN2 NR4A2 NR4A3 RYR1 PTK2B TJP1 EFHD1 NBEAL2 IRS2 TNXB | 1.30e-04 | 658 | 133 | 13 | ctd:C016599 |
| Drug | Simvastatin [79902-63-9]; Up 200; 9.6uM; MCF7; HT_HG-U133A | 1.43e-04 | 193 | 133 | 7 | 3340_UP | |
| Drug | Ethynodiol diacetate [297-76-7]; Down 200; 10.4uM; MCF7; HT_HG-U133A | 1.43e-04 | 193 | 133 | 7 | 5024_DN | |
| Drug | Tenoxicam [59804-37-4]; Up 200; 11.8uM; MCF7; HT_HG-U133A | 1.47e-04 | 194 | 133 | 7 | 4182_UP | |
| Drug | ICI 182,780; Up 200; 0.01uM; MCF7; HT_HG-U133A | 1.47e-04 | 194 | 133 | 7 | 5235_UP | |
| Drug | Dienestrol [84-17-3]; Up 200; 15uM; MCF7; HT_HG-U133A | 1.47e-04 | 194 | 133 | 7 | 6208_UP | |
| Drug | trifluoperazine dihydrochloride; Up 200; 10uM; HL60; HT_HG-U133A | 1.52e-04 | 195 | 133 | 7 | 6183_UP | |
| Drug | Famprofazone [22881-35-2]; Up 200; 10.6uM; PC3; HT_HG-U133A | 1.52e-04 | 195 | 133 | 7 | 4309_UP | |
| Drug | Nitrarine dihydrochloride [20069-05-0]; Up 200; 10.6uM; MCF7; HT_HG-U133A | 1.52e-04 | 195 | 133 | 7 | 4705_UP | |
| Drug | Hesperetin [520-33-2]; Up 200; 13.2uM; MCF7; HT_HG-U133A | 1.57e-04 | 196 | 133 | 7 | 5350_UP | |
| Drug | Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; HL60; HG-U133A | 1.57e-04 | 196 | 133 | 7 | 2035_UP | |
| Drug | Naphazoline hydrochloride [550-99-2]; Up 200; 16.2uM; PC3; HG-U133A | 1.57e-04 | 196 | 133 | 7 | 1886_UP | |
| Drug | aspirin, USP; Down 200; 100uM; MCF7; HT_HG-U133A | 1.57e-04 | 196 | 133 | 7 | 1629_DN | |
| Drug | Tubocurarine chloride pentahydrate (+) [6989-98-6]; Up 200; 5.2uM; HL60; HG-U133A | 1.57e-04 | 196 | 133 | 7 | 1738_UP | |
| Drug | Spiramycin [8025-81-8]; Down 200; 4.8uM; PC3; HT_HG-U133A | 1.57e-04 | 196 | 133 | 7 | 3762_DN | |
| Drug | Hydralazine hydrochloride [304-20-1]; Down 200; 20.4uM; PC3; HT_HG-U133A | 1.57e-04 | 196 | 133 | 7 | 3724_DN | |
| Drug | Thioperamide maleate [106243-16-7]; Up 200; 9.8uM; HL60; HT_HG-U133A | 1.57e-04 | 196 | 133 | 7 | 3055_UP | |
| Drug | Antimycin A [1397-94-0]; Up 200; 7.2uM; HL60; HG-U133A | 1.57e-04 | 196 | 133 | 7 | 1414_UP | |
| Drug | Baclofen (R,S) [1134-47-0]; Up 200; 18.8uM; MCF7; HT_HG-U133A | 1.57e-04 | 196 | 133 | 7 | 1536_UP | |
| Drug | Ornidazole [16773-42-5]; Up 200; 18.2uM; MCF7; HT_HG-U133A | 1.62e-04 | 197 | 133 | 7 | 5483_UP | |
| Drug | Kynurenine, 3-hydroxy (R,S) [2147-61-7]; Up 200; 17.8uM; MCF7; HT_HG-U133A | 1.62e-04 | 197 | 133 | 7 | 5276_UP | |
| Drug | Flavoxate hydrochloride [3717-88-2]; Down 200; 9.4uM; PC3; HT_HG-U133A | 1.62e-04 | 197 | 133 | 7 | 6326_DN | |
| Drug | Levodopa [59-92-7]; Up 200; 20.2uM; MCF7; HT_HG-U133A | 1.62e-04 | 197 | 133 | 7 | 4394_UP | |
| Drug | Morantel tartrate [26155-31-7]; Up 200; 10.8uM; MCF7; HT_HG-U133A | 1.62e-04 | 197 | 133 | 7 | 1676_UP | |
| Drug | Folic acid [59-30-3]; Down 200; 9uM; MCF7; HT_HG-U133A | 1.62e-04 | 197 | 133 | 7 | 7201_DN | |
| Drug | Cefotiam hydrochloride; Up 200; 7.2uM; MCF7; HT_HG-U133A | 1.62e-04 | 197 | 133 | 7 | 3319_UP | |
| Drug | Dicloxacillin sodium salt [13412-64-1]; Up 200; 8.2uM; MCF7; HT_HG-U133A | 1.62e-04 | 197 | 133 | 7 | 3307_UP | |
| Drug | prochlorperazine dimaleate salt; Down 200; 10uM; PC3; HT_HG-U133A | 1.62e-04 | 197 | 133 | 7 | 1215_DN | |
| Drug | Butoconazole nitrate [32872-77-1]; Down 200; 8.4uM; PC3; HT_HG-U133A | 1.62e-04 | 197 | 133 | 7 | 6288_DN | |
| Drug | Ketanserin tartrate hydrate [83846-83-7]; Down 200; 7uM; MCF7; HT_HG-U133A | 1.67e-04 | 198 | 133 | 7 | 4995_DN | |
| Drug | Diazoxide [364-98-7]; Down 200; 17.4uM; MCF7; HT_HG-U133A | 1.67e-04 | 198 | 133 | 7 | 7168_DN | |
| Drug | Minoxidil [38304-91-5]; Down 200; 19.2uM; MCF7; HT_HG-U133A | 1.67e-04 | 198 | 133 | 7 | 4800_DN | |
| Drug | Isocarboxazid [59-63-2]; Down 200; 17.2uM; MCF7; HT_HG-U133A | 1.67e-04 | 198 | 133 | 7 | 3424_DN | |
| Drug | Iocetamic acid [16034-77-8]; Down 200; 6.6uM; PC3; HT_HG-U133A | 1.67e-04 | 198 | 133 | 7 | 4600_DN | |
| Drug | Methantheline bromide [53-46-3]; Up 200; 9.6uM; MCF7; HT_HG-U133A | 1.67e-04 | 198 | 133 | 7 | 6254_UP | |
| Drug | Iobenguane sulfate; Up 200; 10.8uM; HL60; HG-U133A | 1.72e-04 | 199 | 133 | 7 | 1729_UP | |
| Drug | Metampicillin sodium salt [6489-61-8]; Up 200; 10.4uM; MCF7; HT_HG-U133A | 1.72e-04 | 199 | 133 | 7 | 5540_UP | |
| Drug | Thiorphan [76721-89-6]; Down 200; 15.8uM; MCF7; HT_HG-U133A | 1.72e-04 | 199 | 133 | 7 | 6249_DN | |
| Drug | Phenethicillin potassium salt [132-93-4]; Up 200; 10uM; MCF7; HT_HG-U133A | 1.72e-04 | 199 | 133 | 7 | 6105_UP | |
| Drug | Prednicarbate [73771-04-7]; Up 200; 8.2uM; MCF7; HT_HG-U133A | 1.72e-04 | 199 | 133 | 7 | 5544_UP | |
| Drug | Captopril [62571-86-2]; Up 200; 17.2uM; MCF7; HT_HG-U133A | 1.72e-04 | 199 | 133 | 7 | 1488_UP | |
| Drug | Iopromide [73334-07-3]; Down 200; 5uM; MCF7; HT_HG-U133A | 1.72e-04 | 199 | 133 | 7 | 3481_DN | |
| Drug | Epirizole [18694-40-1]; Down 200; 17uM; MCF7; HT_HG-U133A | 1.78e-04 | 200 | 133 | 7 | 1681_DN | |
| Drug | Diloxanide furoate [3736-81-0]; Down 200; 12.2uM; PC3; HT_HG-U133A | 1.78e-04 | 200 | 133 | 7 | 6679_DN | |
| Drug | tebuthiuron | 2.02e-04 | 4 | 133 | 2 | CID000005383 | |
| Drug | (-)-Quinpirole hydrochloride [85760-74-3]; Up 200; 15.6uM; HL60; HT_HG-U133A | 2.84e-04 | 153 | 133 | 6 | 2977_UP | |
| Disease | Intellectual Disability | ZC3H14 DEAF1 BRSK2 NR4A2 PTPN23 PRRT2 SHANK3 CIC KCNK4 PDHX WAC RABL6 KMT2C TAF6 WASF1 | 2.13e-09 | 447 | 134 | 15 | C3714756 |
| Disease | Myopathy, Centronuclear, Autosomal Recessive | 3.65e-07 | 4 | 134 | 3 | C0410204 | |
| Disease | cortical surface area measurement | SHROOM3 BAZ2B BRSK2 DAB1 MPRIP GRIP1 NHSL1 ZNF469 TJP1 TBC1D22A NAV2 AFF1 MTCL1 SSH2 PLEKHA7 PRRC2A TNXB SOS1 | 3.92e-05 | 1345 | 134 | 18 | EFO_0010736 |
| Disease | Autosomal Recessive Centronuclear Myopathy | 4.00e-05 | 15 | 134 | 3 | C3645536 | |
| Disease | Profound Mental Retardation | 4.29e-05 | 139 | 134 | 6 | C0020796 | |
| Disease | Mental Retardation, Psychosocial | 4.29e-05 | 139 | 134 | 6 | C0025363 | |
| Disease | Mental deficiency | 4.29e-05 | 139 | 134 | 6 | C0917816 | |
| Disease | cortical thickness | SHROOM3 COL12A1 KMT2B SPTBN2 DAB1 TACC2 GRIP1 NHSL1 ZNF469 TBC1D22A YLPM1 NAV2 AFF1 MTCL1 SSH2 PLEKHA7 | 4.72e-05 | 1113 | 134 | 16 | EFO_0004840 |
| Disease | Ullrich congenital muscular dystrophy | 1.22e-04 | 4 | 134 | 2 | cv:C4551860 | |
| Disease | Bethlem myopathy | 1.22e-04 | 4 | 134 | 2 | cv:C1834674 | |
| Disease | BETHLEM MYOPATHY 1 | 1.22e-04 | 4 | 134 | 2 | C1834674 | |
| Disease | Ullrich congenital muscular dystrophy 1 | 1.22e-04 | 4 | 134 | 2 | C0410179 | |
| Disease | Bethlem myopathy (is_implicated_in) | 1.22e-04 | 4 | 134 | 2 | DOID:0050663 (is_implicated_in) | |
| Disease | Ullrich congenital muscular dystrophy (is_implicated_in) | 1.22e-04 | 4 | 134 | 2 | DOID:0050558 (is_implicated_in) | |
| Disease | neuroimaging measurement | MRC1 SHROOM3 KMT2B BRSK2 DAB1 TACC2 TFCP2 NHSL1 ZNF469 NAV2 AFF1 DLST SSH2 PLEKHA7 | 3.72e-04 | 1069 | 134 | 14 | EFO_0004346 |
| Disease | autosomal recessive intellectual developmental disorder (implicated_via_orthology) | 5.63e-04 | 8 | 134 | 2 | DOID:0060308 (implicated_via_orthology) | |
| Disease | basophil percentage of granulocytes | 5.66e-04 | 83 | 134 | 4 | EFO_0007995 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 6.65e-04 | 152 | 134 | 5 | DOID:0060041 (implicated_via_orthology) | |
| Disease | Paroxysmal atrial fibrillation | 7.48e-04 | 156 | 134 | 5 | C0235480 | |
| Disease | prostate cancer (is_marker_for) | 7.48e-04 | 156 | 134 | 5 | DOID:10283 (is_marker_for) | |
| Disease | familial atrial fibrillation | 7.48e-04 | 156 | 134 | 5 | C3468561 | |
| Disease | Persistent atrial fibrillation | 7.48e-04 | 156 | 134 | 5 | C2585653 | |
| Disease | Parkinson's disease (implicated_via_orthology) | 7.69e-04 | 157 | 134 | 5 | DOID:14330 (implicated_via_orthology) | |
| Disease | mean platelet volume | LRRC8C ARHGAP32 WIPF1 CDK12 NACA NFASC PRRT2 SHANK3 MPRIP BAZ2A AFF1 IRS2 LYL1 | 7.80e-04 | 1020 | 134 | 13 | EFO_0004584 |
| Disease | Atrial Fibrillation | 8.38e-04 | 160 | 134 | 5 | C0004238 | |
| Disease | retinitis pigmentosa (is_implicated_in) | 8.60e-04 | 41 | 134 | 3 | DOID:10584 (is_implicated_in) | |
| Disease | Neurodevelopmental Disorders | 8.69e-04 | 93 | 134 | 4 | C1535926 | |
| Disease | aspartate aminotransferase measurement | MRC1 BIN1 SHROOM3 COBLL1 ZC3H18 PRAG1 GAB2 BAZ2A EFHD1 MYPN PRRC2A SOS1 | 8.79e-04 | 904 | 134 | 12 | EFO_0004736 |
| Disease | glucagon-like peptide-1 measurement | 8.99e-04 | 10 | 134 | 2 | EFO_0008465 | |
| Disease | serum gamma-glutamyl transferase measurement | SORBS2 BICRA COBLL1 PDHX MPRIP TJP1 EFHD1 NBEAL2 NAV2 SYN2 AFF1 PRRC2A | 9.66e-04 | 914 | 134 | 12 | EFO_0004532 |
| Disease | mean reticulocyte volume | RETREG2 PPRC1 CHD4 BAHD1 WAC ZNF469 SYN2 AFF1 IRS2 LYL1 MAP2K3 | 1.08e-03 | 799 | 134 | 11 | EFO_0010701 |
| Disease | status epilepticus (biomarker_via_orthology) | 1.14e-03 | 100 | 134 | 4 | DOID:1824 (biomarker_via_orthology) | |
| Disease | chronic obstructive pulmonary disease | 1.22e-03 | 688 | 134 | 10 | EFO_0000341 | |
| Disease | asthma, response to diisocyanate | 1.26e-03 | 261 | 134 | 6 | EFO_0006995, MONDO_0004979 | |
| Disease | Autistic Disorder | 1.26e-03 | 261 | 134 | 6 | C0004352 | |
| Disease | Congenital muscular dystrophy | 1.31e-03 | 12 | 134 | 2 | cv:C0699743 | |
| Disease | Autosomal Dominant Myotubular Myopathy | 1.55e-03 | 13 | 134 | 2 | C3661489 | |
| Disease | Centronuclear myopathy | 1.55e-03 | 13 | 134 | 2 | C0175709 | |
| Disease | X-linked centronuclear myopathy | 1.55e-03 | 13 | 134 | 2 | C0410203 | |
| Disease | Myopathy, Centronuclear, 1 | 1.55e-03 | 13 | 134 | 2 | C4551952 | |
| Disease | Congenital Structural Myopathy | 1.55e-03 | 13 | 134 | 2 | C0752282 | |
| Disease | corneal topography | 1.57e-03 | 109 | 134 | 4 | EFO_0004345 | |
| Disease | idiopathic osteonecrosis of the femoral head | 1.72e-03 | 52 | 134 | 3 | EFO_1001930 | |
| Disease | Alzheimer disease | 1.73e-03 | 485 | 134 | 8 | MONDO_0004975 | |
| Disease | Myopathy, Centronuclear, Autosomal Dominant | 1.80e-03 | 14 | 134 | 2 | C1834558 | |
| Disease | Tubular Aggregate Myopathy | 1.80e-03 | 14 | 134 | 2 | C0410207 | |
| Disease | PR interval | 1.96e-03 | 495 | 134 | 8 | EFO_0004462 | |
| Disease | creatinine measurement | SHROOM3 CDK12 SPEG F12 RYR1 GAB2 DLGAP3 TBC1D10B PTPN12 MYPN SYN2 PLEKHA7 | 1.97e-03 | 995 | 134 | 12 | EFO_0004518 |
| Disease | cholesterol to total lipids in large HDL percentage | 2.02e-03 | 55 | 134 | 3 | EFO_0022234 | |
| Disease | free cholesterol to total lipids in very large HDL percentage | 2.02e-03 | 55 | 134 | 3 | EFO_0022288 | |
| Disease | white matter microstructure measurement | 2.09e-03 | 390 | 134 | 7 | EFO_0005674 | |
| Disease | cholesterol:total lipids ratio, intermediate density lipoprotein measurement | 2.29e-03 | 121 | 134 | 4 | EFO_0008595, EFO_0020943 | |
| Disease | nervousness | 2.36e-03 | 16 | 134 | 2 | NCIT_C74532 | |
| Disease | leptin measurement, type 2 diabetes mellitus | 2.36e-03 | 16 | 134 | 2 | EFO_0005000, MONDO_0005148 | |
| Disease | Abnormal behavior | 2.36e-03 | 16 | 134 | 2 | C0233514 | |
| Disease | creatine kinase measurement | 2.47e-03 | 59 | 134 | 3 | EFO_0004534 | |
| Disease | cholesteryl esters to total lipids in large HDL percentage | 2.47e-03 | 59 | 134 | 3 | EFO_0022248 | |
| Disease | acne | 2.58e-03 | 125 | 134 | 4 | EFO_0003894 | |
| Disease | Insulin Resistance | 2.59e-03 | 60 | 134 | 3 | C0021655 | |
| Disease | Insulin Sensitivity | 2.59e-03 | 60 | 134 | 3 | C0920563 | |
| Disease | muscular dystrophy (is_implicated_in) | 2.66e-03 | 17 | 134 | 2 | DOID:9884 (is_implicated_in) | |
| Disease | Dystonia, Limb | 2.66e-03 | 17 | 134 | 2 | C0751093 | |
| Disease | Dystonia, Diurnal | 2.66e-03 | 17 | 134 | 2 | C0393610 | |
| Disease | 1-Methylhistidine measurement | 2.66e-03 | 17 | 134 | 2 | EFO_0021543 | |
| Disease | oral motor function measurement | 2.66e-03 | 17 | 134 | 2 | EFO_0021793 | |
| Disease | monocyte count | RETREG2 BAZ2B SPTBN2 CIC RYR1 HIVEP3 PTK2B BRD2 YLPM1 SYN2 DLST IRS2 SSH2 LYL1 | 2.77e-03 | 1320 | 134 | 14 | EFO_0005091 |
| Disease | Disorder of eye | 2.88e-03 | 212 | 134 | 5 | C0015397 | |
| Disease | sphingosine 1-phosphate measurement | 2.99e-03 | 18 | 134 | 2 | EFO_0800185 | |
| Disease | Dystonia, Paroxysmal | 2.99e-03 | 18 | 134 | 2 | C0393588 | |
| Disease | Congenital Fiber Type Disproportion | 2.99e-03 | 18 | 134 | 2 | C0546264 | |
| Disease | Schizophrenia | 2.99e-03 | 18 | 134 | 2 | cv:C0036341 | |
| Disease | irritable bowel syndrome | 3.05e-03 | 131 | 134 | 4 | EFO_0000555 | |
| Disease | platelet measurement | 3.24e-03 | 315 | 134 | 6 | EFO_0005036 | |
| Disease | systemic lupus erythematosus | 3.60e-03 | 799 | 134 | 10 | MONDO_0007915 | |
| Disease | congenital heart disease (implicated_via_orthology) | 3.86e-03 | 69 | 134 | 3 | DOID:1682 (implicated_via_orthology) | |
| Disease | FEV/FEC ratio | COL6A3 INTS12 SPEG PDHX GAB2 SMTN HIVEP3 PPARGC1B YLPM1 NAV2 MTCL1 SSH2 TNXB | 3.97e-03 | 1228 | 134 | 13 | EFO_0004713 |
| Disease | HIV-1 infection, Susceptibility to viral and mycobacterial infections | 4.06e-03 | 21 | 134 | 2 | EFO_0000180, Orphanet_391311 | |
| Disease | wellbeing measurement | 4.43e-03 | 692 | 134 | 9 | EFO_0007869 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PPPKQEIPAQPSEPP | 141 | Q6ZRG5 | |
| SPPDSPEPKAITPPQ | 681 | Q9NYV4 | |
| KPPLPTSGPAQVPTP | 1331 | P78357 | |
| SSPQPTPPGPEAKEP | 181 | Q9H0I2 | |
| ATQPPAEPPTEPPAQ | 331 | Q9NZN9 | |
| PTPPPAVSEDQPTPS | 1336 | Q9UIF9 | |
| PQSQPPSKSPSPTPA | 1586 | Q9UIF8 | |
| PPPPSPVSEKPLDTI | 1551 | Q9Y6D6 | |
| PQDAPGPKVSPTPEP | 231 | Q5JTC6 | |
| GPKVSPTPEPSPPAT | 236 | Q5JTC6 | |
| LVKLESVPPPPPSPS | 21 | Q99490 | |
| SPPPPTSPEPELAQL | 11 | Q8N302 | |
| PTPPPAPTDPQLTKA | 541 | Q9Y4F5 | |
| QAPAEASPPPIAPKP | 941 | Q53SF7 | |
| NAAPPSSVPPVPPSE | 326 | Q3YEC7 | |
| SPPERPVPGTPKEPS | 306 | Q9Y4B5 | |
| PPLSSPLPEAPQPKE | 1546 | Q9H3S7 | |
| PQPKEEPPVPEAPSS | 1556 | Q9H3S7 | |
| NNSTTPTVPLKPPPP | 351 | Q96CB8 | |
| SKDKDQPPSPSPPPQ | 51 | Q7L1V2 | |
| EPAPLETKPPPSGPQ | 606 | O43747 | |
| KPNPAVPPPLSSSPL | 821 | O75140 | |
| EPPKTPVSSLRPEPP | 201 | Q5HY64 | |
| PPKTRVSSLPPEPPE | 586 | Q5HY64 | |
| PEPPKTRVSSLPPEP | 656 | Q5HY64 | |
| EQQLPPPLSPPSPST | 281 | Q6WCQ1 | |
| PEKASPPASPPIAFP | 4296 | Q8NEZ4 | |
| PPDTTSPEPPDKTSP | 256 | Q13477 | |
| SPEPPDKTSPEPAPQ | 261 | Q13477 | |
| TPLQPPSEPPASPSL | 121 | Q9HCH0 | |
| SPPEKAQPPSPPTAS | 321 | Q9NYG8 | |
| TPKESPAGTPNPTPP | 451 | Q8IWQ3 | |
| PLPDSSPSRKPPPIS | 1186 | Q5SYE7 | |
| PLQPPTVSPSAKQPP | 566 | Q9Y6V0 | |
| SSSLDISAQPPPPPP | 2396 | Q9Y6V0 | |
| DVGPPPPVSKPSEPR | 146 | O00330 | |
| VNPPLPGPKPSIPEE | 671 | O43312 | |
| PEPPTNPQTPPTDAR | 991 | Q9H5P4 | |
| PPQSPPETPQSGPKA | 776 | Q9H792 | |
| SSDTALPPPPVPPKS | 506 | Q9H706 | |
| LPFPSPSKPVEPLNP | 361 | Q9NP85 | |
| EKPVPAAPVPSPVAP | 121 | Q9UK76 | |
| SPPQPPRQDPKSPHI | 26 | Q107X0 | |
| APTPPSTPVPLPEKR | 586 | Q9UMN6 | |
| SVSLIPPPPPPKNVA | 1026 | A7KAX9 | |
| TEPSTAPAPSPPAPK | 481 | Q6NV74 | |
| PQTATQPAISPPPKP | 596 | P51003 | |
| PVPSPSQPPSGKPVS | 186 | P36957 | |
| ATPPQPIAAPPKPEA | 1081 | Q9Y4H2 | |
| PPNEATPTAAPPTLP | 1026 | O94856 | |
| QPDPRPDSQPTPKPA | 141 | Q7Z6L0 | |
| SIPVTSEPPALPPKP | 1921 | Q8N1I0 | |
| PPPVPSRKPDQPSLT | 456 | O75553 | |
| TVKPTEAPTEPPTPP | 2291 | Q99715 | |
| SHIATKQPPPTPPLP | 476 | I3L273 | |
| TTPPISSIPPLQEPP | 251 | P28324 | |
| LAVPPPTPTKAAPPA | 426 | O75398 | |
| APPGVDTPPPSRPEK | 1621 | P12111 | |
| ELAPVPPRASPKPPT | 596 | O95886 | |
| PSKKQQEPAAPPPPE | 481 | O75061 | |
| LPKPPSPAPSSEDPG | 96 | Q8TBE0 | |
| FPSRPPPPQPKVSSQ | 786 | Q13443 | |
| PPKPASPGPPQVEEV | 31 | P12980 | |
| PSPTPAPPQKEQPPA | 551 | Q3KQU3 | |
| PKPEPEPPARAPTAS | 36 | Q9BUP0 | |
| EPPKTPVSSLRPEPP | 316 | Q5JRC9 | |
| PPISPPKTPVPQASS | 11 | Q5BKX5 | |
| PKTPVPQASSIPSPP | 16 | Q5BKX5 | |
| EPTAFQEPPPKPSRP | 706 | Q14289 | |
| PKAPPPNSPPALVSS | 391 | Q9Y3R0 | |
| DPLPPVTSPVKAPTP | 396 | O00499 | |
| HQPPPPPATLKVAEP | 1331 | Q9NZM4 | |
| RPPDADPNTPSPKPL | 521 | Q14839 | |
| EPTPEPPKKQAPPSP | 4516 | P21817 | |
| PASPSPEPPVSKPVA | 826 | Q5VV67 | |
| TETPAPNLPPTPTPL | 291 | P25940 | |
| SKPPAPNPTPPRNLD | 31 | P46734 | |
| KPEPTPAPQDNPPVT | 786 | P22897 | |
| SPQEPSPPSPPVSLI | 351 | P43354 | |
| KQSPPSTPTTPAFPP | 136 | Q92570 | |
| APPKPQPTTRTPPQS | 321 | P00748 | |
| DSAIAPPPRPPKPSQ | 346 | Q9UQC2 | |
| ASLPAQSPPPPEPAD | 336 | Q86TM6 | |
| AAPPQPSPPPTKFIV | 526 | P49848 | |
| KDPDSSKTPPQRPPP | 441 | Q92777 | |
| SPEPAAPPRPQTPEN | 131 | O15240 | |
| PPSVTPIFLEPPPKE | 636 | Q8WZA1 | |
| APPKPPTESPAEPSD | 1316 | Q6ZNJ1 | |
| PVPPPDNAATPLPAT | 316 | Q9H6K5 | |
| PASTPPDSPPLQAPL | 646 | Q9H6K5 | |
| LQAPPSPLTTPPPET | 791 | Q9H6K5 | |
| VTSPPPPPSSHEKEP | 321 | Q8IVL1 | |
| EPEKQDSPPPKPPRT | 326 | Q05209 | |
| APSPSILPPVPQDSP | 461 | Q8NC44 | |
| STSESKPPPQPSPPT | 856 | Q6IQ23 | |
| STPAPPPAVPKELPA | 516 | P48634 | |
| PSSAPPSPAPEKPSA | 131 | Q86YN6 | |
| PSPAPEKPSAPAPEV | 136 | Q86YN6 | |
| ATPYSPPPPETEKVP | 1006 | Q14524 | |
| KATSSPTFEPLPPPP | 1516 | Q8TF72 | |
| SAVPVSPVPQSPIPP | 341 | Q9BTA9 | |
| ETPPPLPPKSPSFQA | 321 | A6NGB9 | |
| TKGTDEVPVPPPVPP | 1141 | Q07889 | |
| PPPPVPTEPKQPTEE | 11 | Q15459 | |
| PPKVPPREPLSPSNS | 316 | Q9UJM3 | |
| FKDASSPVPPPHVPP | 161 | O94875 | |
| LTPANPPPPEVSNPK | 56 | P25440 | |
| PEKPPSSSAPPSAPQ | 441 | P51825 | |
| PPPKAQSVSPVQAPP | 896 | Q96RK0 | |
| NPDDIDPTPTPTPTP | 871 | Q14CN2 | |
| AEENPPSTVLPPPSP | 481 | Q14028 | |
| PKEAATDPPAPRTPP | 1176 | Q14028 | |
| NVKESECPLPPPSPP | 2106 | A4UGR9 | |
| LPPGKEATTPTPEPP | 1981 | Q9C0A1 | |
| QPPEPTATAPPKPPE | 2406 | Q9C0A1 | |
| KQPPAPEPTASVPPG | 2096 | O15020 | |
| PAPEPPPEPTKVTVQ | 2916 | Q15772 | |
| KDPPMSPDPESPSPQ | 621 | Q76I76 | |
| PASGKPSSEPPPAPE | 1336 | Q9BYB0 | |
| PPPPVTDNLLPTTTP | 316 | Q12800 | |
| APDPSLPPLAQSPPK | 606 | Q96PX9 | |
| PQPPKDSATPLSPQP | 521 | Q8TCT7 | |
| APLPPAPATEASKPP | 1561 | P22105 | |
| ASTEPPTPEPPIKPR | 2291 | P22105 | |
| EDKPLAQFPSPPPAP | 821 | Q5T1R4 | |
| PDKNVPPPSIEPLTP | 221 | Q9NW97 | |
| SAPVKQPPPLAPQSP | 276 | P46937 | |
| SPPPSQPDPEHLDKP | 486 | O94885 | |
| PKPQLPSGPESPEPA | 101 | Q4KMP7 | |
| PPRPDVGSKPDSIPP | 171 | O43516 | |
| PSQDPTPAATPETPP | 2446 | O95359 | |
| DTPSKPVLPLVPPSP | 396 | Q15569 | |
| SGIETFSPPPPPPKS | 706 | Q86YV5 | |
| QQKPRPEAEPPSPPS | 121 | Q8WUA7 | |
| PPPPPVIKPQTSAVE | 1556 | P49750 | |
| KAPPPLPAATPDPQT | 896 | Q96JG9 | |
| ALPSNTKPLPPPPTQ | 1236 | Q07157 | |
| NPVTSTPAKPSSPPP | 371 | Q6NXT4 | |
| SEPLPKPPASAPPSI | 611 | Q8TEC5 | |
| PPSPPSQVIPASEPK | 471 | Q92558 | |
| PKPAVAPPAPPSSSQ | 666 | Q6PJT7 | |
| PPPSPPKTTSPEPQE | 236 | P53814 | |
| APPPAPPQATKTTAP | 641 | Q86VM9 | |
| EAPKADQPPSPLPQP | 331 | Q5EBL2 | |
| SEVPKSPEPPPVPVL | 981 | Q96PN7 | |
| SPVISKDQSPPPSPP | 661 | Q9P206 | |
| ASTTPLPPPKPSPAN | 76 | Q8TDW0 | |
| LPPPKPSPANPITVE | 81 | Q8TDW0 | |
| AATPTPSLPPPPAND | 21 | Q9UPR5 | |
| TLPAVTPPSPKEPPA | 1466 | E9PAV3 | |
| KEAPTPPAVTPPSPE | 1611 | E9PAV3 | |
| PPAVTPPSPEKGPAT | 1616 | E9PAV3 | |
| SPPHSEPPSVEQPPK | 561 | Q86TC9 |